var title_f13_59_14256="Course of BK-induced nephropathy";
var content_f13_59_14256=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F83389&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F83389&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 554px\">",
"   <div class=\"ttl\">",
"    Graph showing typical course of viruria, viremia, and BK-induced nephropathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 534px; height: 327px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Prototypical course of polyomavirus-associated nephropathy (PVAN) and opportunities for timely intervention. The vast majority of cases of PVAN are preceded by an asymptomatic period of persistent and significant viruria (Vr). This can be demonstrated by polymerase chain reaction based studies (&gt;10E+05 viral copies/mL) or by urine cytology (decoy cells present for &ge;2 months). Both BK and JC Vr manifest with decoy cells but only BK Vr increases the risk for graft loss or shortened graft survival. Sustained BK Vr is typically followed within weeks by the development of viremia (Vm). Significant, sustained Vm (&gt;5000 BK copies/mL for three consecutive weeks) characterizes patients with high, uncontrolled viral replication leading to parenchymal injury. Progression of PVAN leads to eventual deterioration the graft function. In patients with uncomplicated PVAN, appearance of Vr and Vm precede the increase in serum creatinine (Cr) by weeks or months.",
"    <br/>",
"    Histologic diagnosis of PVAN (Bx+). The statistical possibility to achieve a histologic diagnosis by needle graft biopsy (Bx) is directly proportional to the time elapsed from the initiation of the Vm and correlates with the overall level of viral loads (Vr, Vm). Negative biopsy samples are common in early PVAN due to heterogeneous renal involvement. Longer and more pronounced Vm is associated with more severe histologic disease/pattern and larger number of cells with viral cytopathic changes (SV40+ cells).",
"    <br/>",
"    (E-G) options for clinical intervention in PVAN: (E) preemptive intervention: In patients with Vr and Vm, progressive and customized decrease in immunosuppression before significant renal scarring has occurred leads to resolution of the infection in 85 to 90 percent of cases with long term preservation of graft function. Risk of acute rejection is low (10 to 15 percent). Intervention is not indicated in the absence of Vm (ie, Vr only). (F) Obligatory intervention. Late diagnosis and intervention once graft dysfunction is evident decreases the likelihood of viral clearance and is associated with higher rates of premature graft loss (30 versus 10 percent). (G) Ineffectual, late intervention. The late stage of PVAN resembles clinically and hitologically end stage renal disease from other causes. With progressive obliteration of the renal tubules (the primary target of BK infection) there is progressive decrease of Vr and Vm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Ramos E, Drachenberg CB, Wali R, Hirsch HH. The decade of polyomavirus BK-associated nephropathy: state of affairs. Transplantation 2009; 87:621. Copyright &copy; 2009 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_59_14256=[""].join("\n");
var outline_f13_59_14256=null;
var title_f13_59_14257="Cephalad retraction panniculus";
var content_f13_59_14257=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F50505&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F50505&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Panniculus retracted cephalad prior to incision",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Panniculus retracted upward and held by wide tape to allow placement of incision below.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_59_14257=[""].join("\n");
var outline_f13_59_14257=null;
var title_f13_59_14258="Paget disease of bone (osteitis deformans)";
var content_f13_59_14258=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Paget disease of bone (osteitis deformans) (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?13/59/14258/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/59/14258/contributors\" id=\"au913\">",
"       Margaret Seton, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?13/59/14258/contributors\">",
"       Section Editors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/59/14258/contributors\" id=\"se5724\">",
"       Peter H Schur, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/59/14258/contributors\" id=\"se6176\">",
"       Marc K Drezner, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?13/59/14258/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/59/14258/contributors\" id=\"de4792\">",
"       Jerry M Greene, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?13/59/14258?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      PAGET DISEASE OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Paget disease of bone is a disorder of an aging skeleton in which some bones grow abnormally, affecting their size and shape. This can sometimes lead to pain in the bone and in the nearby joints. The condition is slightly more common in men, in persons older than 55 or 60 years of age, in those with family members affected by Paget disease, and in those of European ancestry. Paget disease may affect one bone or many bones and tends to be found in the skull, spine, pelvis, and long bones of the extremity (femur, tibia). A curious aspect of Paget disease is that it does not spread from bone to bone. In a given individual, the bones affected by Paget disease usually remain constant throughout a lifetime. The reason for this is unclear.",
"    </p>",
"    <p>",
"     There is a type of breast cancer that is referred to as Paget disease of the breast; this is not related to Paget disease of bone and will not be discussed here. Juvenile Paget disease, an autosomal recessive bone disease of children, is not related to this disorder of adult bone either.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      NORMAL BONE GROWTH",
"     </span>",
"    </p>",
"    <p>",
"     To understand Paget disease, it is important to remember that bones are active, living tissues vital to human movement, are critical as sources of calcium, and are birthplace to the blood cells in our body. In the work they do, bones constantly remodel, cleaning out old bone and replacing it with new. Osteoclasts are the cells that remove bone. Their role is closely linked to osteoblasts that refill the cavities left by osteoclasts. In Paget disease, the speed with which this remodeling occurs is abnormal, resulting in excessive bone that lacks the strength and shape of normal bone.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      PAGET DISEASE CAUSES",
"     </span>",
"    </p>",
"    <p>",
"     The cause of Paget disease is unknown. A person's genes may predispose them to developing Paget disease, while viruses and other environmental exposures may trigger its development.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      PAGET DISEASE SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     Most people with Paget disease have no signs or symptoms of bone disease. When there are symptoms, such as pain or deformity, it can be related to Paget disease itself or to complications that occur because of abnormal bone growth.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Pain",
"     </span>",
"     &nbsp;&mdash;&nbsp;Pain may develop directly from a bone affected by the Paget disease or, more often, from complications related to the presence of misshapen bone. Examples of complications include arthritis (when bones near a joint are affected) and numbness or weakness (due to pressure from a bone on a nerve).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Deformities",
"     </span>",
"     &nbsp;&mdash;&nbsp;Abnormal bone growth may cause visible deformities. This is particularly true in affected limbs of the lower extremity or in the skull. If the leg is affected, there can be bowing of the leg, which can cause a limp or can present with back or joint pain due to the abnormal gait. If the skull is involved, the head may slowly enlarge.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Fractures",
"     </span>",
"     &nbsp;&mdash;&nbsp;The abnormal bone of Paget disease is more likely to fracture when exposed to weight-bearing stresses.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Bone tumors",
"     </span>",
"     &nbsp;&mdash;&nbsp;Although rare, the risk of a tumor arising in pagetic bone (both cancerous and noncancerous) is increased in people with Paget disease. This complication occurs in less than 1 percent of people with Paget disease and has been reported most commonly in those with several affected bones.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Calcium and phosphate",
"     </span>",
"     &nbsp;&mdash;&nbsp;The breakdown and build up of bone is essential in regulating the levels of calcium and phosphorus in the blood. In most people with Paget disease, these levels remain normal. However, certain conditions can cause the balance to be disrupted, such as inactivity (eg, after a fracture) or the presence of a second disorder such as hyperparathyroidism (overactive parathyroid glands). (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/52/29507?source=see_link\">",
"      \"Patient information: Primary hyperparathyroidism (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H22368471\">",
"     <span class=\"h2\">",
"      Hearing loss",
"     </span>",
"     &nbsp;&mdash;&nbsp;Paget disease will not cause problems at a site distant to the affected bone, so hearing loss in patients with Paget disease is only caused by Paget disease when pagetic bone affects the skull.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h1\">",
"      PAGET DISEASE DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     Most people are diagnosed with Paget disease using a combination of a blood tests and radiographic imaging (x-rays or bone scans).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Blood test",
"     </span>",
"     &nbsp;&mdash;&nbsp;A blood test for alkaline phosphatase is usually elevated in people with Paget disease. Alkaline phosphatase is an enzyme that is normally produced in several organs, including the bones, where it is made by osteoblasts.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Bone scan",
"     </span>",
"     &nbsp;&mdash;&nbsp;A bone scan may be done to confirm the diagnosis of Paget disease",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     to identify other bones that are involved. A bone scan is a test that can detect new areas of bone growth using medication that is injected into a vein; the scan may examine bones of the entire body or of a single area.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      X-rays",
"     </span>",
"     &nbsp;&mdash;&nbsp;Paget disease may be diagnosed with x-rays. Changes in the bones seen on x-ray may include thickening of the outside of the bone (the cortex) and enlargement or deformity of the bone itself. X-rays are usually done after a bone scan to evaluate potentially affected bones. The information gained from an x-ray is usually sufficient to make the diagnosis of Paget disease.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H14\">",
"     <span class=\"h1\">",
"      PAGET DISEASE TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     Many patients with Paget disease do not have symptoms and do not need treatment. However, treatment may be recommended to decrease the risk of future complications, even if the person has no current symptoms. This may include people who have involvement of the skull, spine, or lower limbs.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Medications",
"     </span>",
"     &nbsp;&mdash;&nbsp;Patients who have pain, bone deformities, or other symptoms related to Paget are usually treated with medications that stop the abnormal bone turnover. The treatment of choice is an aminobisphosphonate.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h3\">",
"      Bisphosphonates",
"     </span>",
"     &nbsp;&mdash;&nbsp;Aminobisphosphonates inhibit the breakdown and removal of bone by inhibiting the osteoclast. The aminobisphosphonates include alendronate, risedronate, pamidronate, and zoledronic acid. The first two are given by mouth, and the last two are given by infusion. The older bisphosphonates, etidronate and tiludronate, are not aminobisphosphonates and are not usually recommended for people with Paget disease of bone because their potency is less.",
"    </p>",
"    <p>",
"     Aminobisphosphonates are usually given for a limited period of time, followed by a period of monitoring. (See",
"     <a class=\"local\" href=\"#H19\">",
"      'Medication monitoring'",
"     </a>",
"     below.) These drugs offer the possibility of a long-lasting remission. However, if problems recur, treatment may be repeated. While taking a bisphosphonate, it is important to consume calcium and vitamin D every day in amounts recommended by your clinician. Calcium and vitamin D can be taken as a supplement (",
"     <a class=\"graphic graphic_table graphicRef70454 \" href=\"UTD.htm?36/37/37468\">",
"      table 1",
"     </a>",
"     ); many foods and drinks contain calcium (",
"     <a class=\"graphic graphic_table graphicRef67824 \" href=\"UTD.htm?28/58/29611\">",
"      table 2",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Zoledronic acid is given as an injection into a vein over 15 to 20 minutes.",
"      </li>",
"      <li>",
"       Alendronate and risedronate are taken as a pill for two to six months. These need to be taken first thing in the morning on an empty stomach with a full 8 ounce (approximately 240 mL) glass of plain water (not sparkling). Liquids other than plain water, such as mineral water, coffee, or juice, may interfere with absorption of the medication from the stomach and intestine. After taking alendronate or risedronate, the person must remain upright so the medicine reaches the stomach (sitting or standing, not lying down) and must wait 30 minutes before eating or drinking anything.",
"      </li>",
"      <li>",
"       Pamidronate is an older, less potent aminobisphosphonate that is also effective in many patients with Paget disease. It is given into a vein over two to four hours. Reports of resistance to pamidronate and more frequent biochemical relapses in patients with Paget disease have led clinicians to choose zoledronic acid more often than pamidronate when giving an infusion.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h3\">",
"      Side effects of bisphosphonates",
"     </span>",
"     &nbsp;&mdash;&nbsp;Most people who take bisphosphonates do not have any serious side effects related to the medication. Transient fever or flu-like symptoms are the most common side effects.",
"    </p>",
"    <p>",
"     There has been concern about use of aminobisphosphonates in people who require invasive dental work. A problem known as avascular necrosis or osteonecrosis of the jaw has rarely developed in people who used these drugs. This is seen more commonly in people with cancer who are given a monthly dose of the aminobisphosphonate. The risk of this problem is much less in people who take bisphosphonates for Paget disease. However, it is sensible to have dental extractions done prior to treatment for Paget disease of bone as trauma seems to predispose to this.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h3\">",
"      Calcitonin",
"     </span>",
"     &nbsp;&mdash;&nbsp;Synthetic calcitonin is a hormone that is given as an injection under the skin several times a week. Calcitonin may be recommended for people who are unable to tolerate the new aminobisphosphonates because of kidney disease or intolerable side effects. Calcitonin is a safe drug that can ease pain and is partially effective in reducing new bone growth.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H19\">",
"     <span class=\"h3\">",
"      Medication monitoring",
"     </span>",
"     &nbsp;&mdash;&nbsp;During and after treatment, blood tests are performed every three to six months to check the level of alkaline phosphatase; a falling level is a good indicator that treatment is working. Other markers of bone turnover may also be recommended by one&rsquo;s clinician.",
"    </p>",
"    <p>",
"     When it appears that the medication is effectively reducing new bone formation and the pain has eased, annual visits to one&rsquo;s clinician may suffice. If the alkaline phosphatase level rises or if symptoms worsen, these are good reasons to re-assess therapy.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h2\">",
"      Other treatments",
"     </span>",
"     &nbsp;&mdash;&nbsp;People with Paget disease may have pain that is related to Paget as well as pain that is unrelated to the condition. As the skeleton ages, a number of conditions can cause pain in the bones",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     joints, including the following:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Arthritis of the hip, spine, or knee",
"      </li>",
"      <li>",
"       A pinched nerve (eg, sciatica)",
"      </li>",
"      <li>",
"       Compression fractures of the spine related to osteoporosis",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Pain medications (eg, acetaminophen or ibuprofen) are recommended as needed for treatment of pain that does not improve with the treatment of Paget disease. Consultation with a healthcare provider is recommended to determine which medications",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     other treatments may be most helpful. In some cases, a cane or physical therapy may be recommended.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h2\">",
"      Surgery",
"     </span>",
"     &nbsp;&mdash;&nbsp;The joints adjacent to affected bones may become stiff and painful due to arthritis. Some patients with severe arthritis pain benefit from surgery to replace the joint. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/13/21717?source=see_link\">",
"      \"Patient information: Total knee replacement (arthroplasty) (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/30/21987?source=see_link\">",
"      \"Patient information: Total hip replacement (arthroplasty) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Most people who plan to have surgery are treated for Paget disease of bone for at least two to three months before surgery. This can help to decrease blood flow to the bone, which will help decrease bleeding during surgery.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3255975\">",
"     <span class=\"h2\">",
"      Outcomes",
"     </span>",
"     &nbsp;&mdash;&nbsp;Most people with Paget disease live long, healthy lives troubled mostly by the musculoskeletal problems imposed by the disease or by other problems of aging.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H22\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1784821877\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11170107\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/59/12211?source=see_link\">",
"      Patient information: Paget disease of bone (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11170123\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/52/29507?source=see_link\">",
"      Patient information: Primary hyperparathyroidism (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/13/21717?source=see_link\">",
"      Patient information: Total knee replacement (arthroplasty) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/30/21987?source=see_link\">",
"      Patient information: Total hip replacement (arthroplasty) (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/50/7978?source=see_link\">",
"      Clinical manifestations and diagnosis of Paget disease of bone",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33287?source=see_link\">",
"      Diagnosis and classification of osteoarthritis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/22/28007?source=see_link\">",
"      Etiology of hypercalcemia",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/22/10602?source=see_link\">",
"      Treatment of Paget disease of bone",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"        www.nlm.nih.gov/medlineplus/healthtopics.html",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       American Academy of Orthopaedic Surgeons",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://orthoinfo.aaos.org/\">",
"        file://orthoinfo.aaos.org/",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       American College of Rheumatology",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.rheumatology.org/\">",
"        www.rheumatology.org",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       Arthritis Foundation",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.arthritis.org/conditions/DiseaseCenter/Pagets_disease.asp\">",
"        www.arthritis.org/conditions/DiseaseCenter/Pagets_disease.asp",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       Paget Foundation for Paget's Disease of Bone and Related Disorders",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.paget.org/\">",
"        www.paget.org",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?13/59/14258/abstract/1-3\">",
"      1-3",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 14, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?13/59/14258?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14258/abstract/1\">",
"      Siris ES. Epidemiological aspects of Paget's disease: family history and relationship to other medical conditions. Semin Arthritis Rheum 1994; 23:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14258/abstract/2\">",
"      Whyte MP. Clinical practice. Paget's disease of bone. N Engl J Med 2006; 355:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14258/abstract/3\">",
"      Seton M, Moses AM, Bode RK, Schwartz C. Paget's disease of bone: the skeletal distribution, complications and quality of life as perceived by patients. Bone 2011; 48:281.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f13_59_14258=[""].join("\n");
var outline_f13_59_14258=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           PAGET DISEASE OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           NORMAL BONE GROWTH",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           PAGET DISEASE CAUSES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H4\">",
"           PAGET DISEASE SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H10\">",
"           PAGET DISEASE DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H14\">",
"           PAGET DISEASE TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H22\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          TABLES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"UTD.htm?36/37/37468\" title=\"table 1\">",
"           Calcium supplements PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"UTD.htm?28/58/29611\" title=\"table 2\">",
"           Foods with calcium PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f13_59_14259="Mycoplasma pneumonia lung imaging B";
var content_f13_59_14259=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F71707&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F71707&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 617px\">",
"   <div class=\"ttl\">",
"    Acute bronchiolitis caused by Mycoplasma pneumoniae",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 597px; height: 203px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Magnified view of the right lower lung zone from a posteroanterior chest radiograph shows a reticulonodular pattern.",
"    <br>",
"     (B) High-resolution computed tomography (CT) scan (1-mm collimation) at the level of the inferior pulmonary veins shows multiple bilateral centrilobular nodular and branching linear opacities (\"tree-in-bud\" pattern) (arrows) in both lower lobes. The patient was a previously healthy 24-year-old man. Immunofluorescent microscopy of sputum revealed M. pneumoniae organisms.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced with permission from: Pulmonary infection: Basic concepts. In: Imaging of Pulmonary Infections, M&uuml;ller NL, Franquet T, Lee KS (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2007. Copyright &copy; 2007 Lippincott Williams &amp; Wilkins.",
"     </div>",
"     <div class=\"contractual\">",
"      <br/>",
"      <a href=\"file://www.lww.com\">",
"       file://www.lww.com",
"      </a>",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_59_14259=[""].join("\n");
var outline_f13_59_14259=null;
var title_f13_59_14260="Methylnaltrexone: Patient drug information";
var content_f13_59_14260=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Methylnaltrexone: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/29/2516?source=see_link\">",
"     see \"Methylnaltrexone: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F6028565\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Relistor&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F6860881\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Relistor&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10015019\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat very hard stools (constipation) caused by some drugs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10015018\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702510",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to methylnaltrexone or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a bowel block.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10015023\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10015024\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698017",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dizziness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698108",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Gas.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10015026\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10015021\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696001",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into the fatty part of the skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Your doctor may teach you how to give the shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Move the site where you give the shot with each shot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696118",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away needles in a needle/sharp disposal box and take the box back to your doctor when it is full.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2857459",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you stop taking your pain drugs, talk with your doctor before taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10015022\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696480",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take more often than every 24 hours unless told to do so by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10015027\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature. Do not freeze.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10015028\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12081 Version 29.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-83.177.194.223-190351C039-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_59_14260=[""].join("\n");
var outline_f13_59_14260=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6028565\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6860881\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015019\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015018\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015023\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015024\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015026\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015021\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015022\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015027\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015028\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?2/29/2516?source=related_link\">",
"      Methylnaltrexone: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_59_14261="Adenosine: Pediatric drug information";
var content_f13_59_14261=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Adenosine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?43/26/44454?source=see_link\">",
"    see \"Adenosine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?3/23/3444?source=see_link\">",
"    see \"Adenosine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F130686\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Adenocard&reg; IV;",
"     </li>",
"     <li>",
"      Adenoscan&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F130687\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Adenocard&reg;;",
"     </li>",
"     <li>",
"      Adenosine Injection, USP;",
"     </li>",
"     <li>",
"      PMS-Adenosine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1050804\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antiarrhythmic Agent, Miscellaneous",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11426611\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Paroxysmal supraventricular tachycardia: Rapid I.V.: Initial dose: 0.05-0.1 mg/kg; if not effective within 1-2 minutes, increase dose by 0.05-0.1 mg/kg increments every 1-2 minutes to a maximum single dose of 0.3 mg/kg or until termination of PSVT",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1050797\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?43/26/44454?source=see_link\">",
"      see \"Adenosine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Paroxysmal supraventricular tachycardia:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     PALS Guidelines, 2010: Infants and Children: Rapid I.V.; I.O.: Initial: 0.1 mg/kg (maximum: 6 mg); if not effective, give 0.2 mg/kg (maximum: 12 mg) (PALS, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Manufacturer's recommendations: Rapid I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants, Children, and Adolescents &lt;50 kg: Initial dose: 0.05-0.1 mg/kg; if not effective within 1-2 minutes, increase dose by 0.05-0.1 mg/kg increments every 1-2 minutes to a maximum single dose of 0.3 mg/kg or until termination of PSVT",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children and Adolescents &ge;50 kg and Adults: 6 mg, if not effective within 1-2 minutes, 12 mg may be given; may repeat 12 mg bolus if needed.",
"     <b>",
"      Note:",
"     </b>",
"     Initial dose of adenosine should be reduced to 3 mg if patient is currently receiving carbamazepine or dipyridamole, has a transplanted heart, or if adenosine is administered via central line (ACLS, 2010).",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F130666\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]: 3 mg/mL (2 mL, 4 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adenocard&reg; IV: 3 mg/mL (2 mL, 4 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adenoscan&reg;: 3 mg/mL (20 mL, 30 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F130651\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1050808\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral: For rapid bolus I.V. use, administer over 1-2 seconds at peripheral I.V. site closest to patient's heart (I.V. administration into lower extremities may result in therapeutic failure or requirement of higher doses); follow each bolus with NS flush (infants and children: 5-10 mL; adults: 20 mL);",
"     <b>",
"      Note:",
"     </b>",
"     The use of two syringes (one with adenosine dose and the other with NS flush) connected to a T-connector or stopcock is recommended for I.V. and I.O. administration (PALS, 2010). If given I.V. peripherally in adults, elevate the extremity for 10-20 seconds after the NS flush. To administer doses &lt;600 mcg (0.2 mL of commercial product), a dilution with NS (final concentration: 300 mcg/mL) may be made.",
"     <b>",
"      Note:",
"     </b>",
"     Preliminary results in adults suggest adenosine may be administered via a",
"     <b>",
"      central line",
"     </b>",
"     at lower doses (eg, Adults: Initial dose: 3 mg); FDA approved labeling for pediatric patients weighing &lt;50 kg states that doses listed may be administered either peripherally or centrally (further studies are needed)",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F130734\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     LR, D",
"     <sub>",
"      5",
"     </sub>",
"     W, LR, NS.",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Abciximab",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1050800\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at controlled room temperature 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F); do",
"     <b>",
"      not",
"     </b>",
"     refrigerate, precipitation may occur (dissolve  by warming to room temperature); contains no preservatives, discard unused portion",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1050807\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (eg, Wolff-Parkinson-White syndrome) (FDA approved in all ages);",
"     <b>",
"      Note:",
"     </b>",
"     When clinically advisable, appropriate vagal maneuvers should be attempted prior to adenosine administration; used in PALS algorithms for probable supraventricular tachycardia, stable regular monomorphic wide-complex tachycardia as a therapeutic (if arrhythmia supraventricular) and diagnostic maneuver; used in adult ACLS for stable narrow-complex regular tachycardias, unstable narrow-complex regular tachycardias while preparations are made for electrical cardioversion, stable regular monomorphic wide-complex tachycardia as a therapeutic (if arrhythmia supraventricular) and diagnostic maneuver; investigationally  used as a continuous infusion for the treatment of primary pulmonary hypertension in adults and persistent pulmonary hypertension of the newborn (PPHN)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F5174500\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F130733\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: AV block, chest pain, facial flushing, hypotension, palpitation, ST segment depression, transient new arrhythmia (eg, atrial premature contractions, atrial fibrillation, PVCs) after cardioversion",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Apprehension, dizziness, headache, lightheadedness, nervousness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: GI discomfort, nausea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Discomfort of neck, throat, jaw; numbness, paresthesia, upper extremity discomfort",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Dyspnea, chest pressure/discomfort, hyperventilation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Asystole (prolonged), atrial fibrillation, bradycardia, bronchospasm, burning sensation, blurred vision, hypertension (transient), injection site reaction, intracranial pressure increased, loss of consciousness, metallic taste, MI, respiratory arrest, seizure, torsade de pointes, ventricular fibrillation, ventricular tachycardia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1050812\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to adenosine or any component; second and third degree A-V block or sick sinus syndrome unless pacemaker placed",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1050796\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Bronchoconstriction may occur in asthmatics (avoid use in patients with bronchospasm or bronchoconstriction); use with caution in patients with underlying dysfunction of sinus or A-V node, obstructive lung disease, and those taking digoxin or verapamil; initial adenosine dose should be significantly decreased in patients receiving dipyridamole",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1050795\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Heart block, including transient or prolonged asystole may occur as well as other arrhythmias; episodes of asystole or other arrhythmias may be fatal; if arrhythmia is not due to re-entry pathway through A-V node or sinus node (ie, atrial fibrillation, flutter, or tachycardia or ventricular tachycardia), adenosine will not terminate the arrhythmia but can produce transient ventriculoatrial or A-V block; possible mutagenic effects",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298689\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F130660\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Caffeine: May diminish the therapeutic effect of Adenosine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: May enhance the adverse/toxic effect of Adenosine. Specifically, the risk of higher degree heart block may be increased. Management: Consider using a lower initial dose of adenosine in patients who are receiving carbamazepine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Digoxin: May enhance the adverse/toxic effect of Adenosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dipyridamole: May enhance the therapeutic effect of Adenosine. Dose reduction of adenosine may be needed. Management: Reduction of the initial dose of adenosine may be warranted.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nicotine: May enhance the AV-blocking effect of Adenosine. Nicotine may enhance the tachycardic effect of Adenosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Theophylline Derivatives: May diminish the therapeutic effect of Adenosine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F130662\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F130675\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. Adenosine is an endogenous substance and adverse fetal effects would not be anticipated. Case reports of administration during pregnancy have indicated no adverse effects on fetus or newborn attributable to adenosine. ACLS guidelines suggest use is safe and effective in pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1050803\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Continuous ECG, heart rate, blood pressure, respirations",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1050794\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Slows conduction time through the A-V node, interrupting the re-entry pathways through the A-V node, restoring normal sinus rhythm",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1050810\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Rapid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Very brief",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1050811\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Removed from systemic circulation primarily by vascular endothelial cells and erythrocytes (by cellular uptake); rapidly metabolized intracellularly; phosphorylated by adenosine kinase to adenosine monophosphate (AMP) which is then incorporated into high-energy pool; intracellular adenosine is also deaminated by adenosine deaminase to inosine; inosine can be metabolized to hypoxanthine, then xanthine and finally to uric acid.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: &lt;10 seconds",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1050813\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not effective in atrial flutter, atrial fibrillation, or ventricular tachycardia; short duration of action is an advantage as adverse effects are usually rapidly self-limiting; effects may be prolonged in patients with denervated transplanted hearts. Individualize treatment of prolonged adverse effects: Give I.V. fluids for hypotension, aminophylline/theophylline may antagonize effects.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Limited information is available regarding the use of adenosine for the treatment of persistent pulmonary hypertension of the newborn (PPHN); efficacy, optimal dose, and duration of therapy is not established; a randomized, masked, placebo-controlled pilot study of 18 term infants with PPHN used initial doses of 25 mcg/kg/minute (n=9); after 30 minutes, doses were increased to 50 mcg/kg/minute if no improvement in PaO",
"     <sub>",
"      2",
"     </sub>",
"     was observed; all patients received study drug via central line into the right atrium (inserted via the umbilical vein); significant improvement in oxygenation was observed in 4 of 9 newborns receiving 50 mcg/kg/minute; hypotension or tachycardia were not observed; further studies are needed (Kondur, 1996).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Adenosine is also available as Adenoscan&reg;, which is used in adults as an adjunct to thallium-201 myocardial perfusion scintigraphy; see package insert for further information on this use.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Eubanks AP and Artman M, &ldquo;Administration of Adenosine to a Newborn of 26 Weeks' Gestation,&rdquo;",
"      <i>",
"       Pediatr Cardiol",
"      </i>",
"      , 1994, 15(3):157-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/59/14261/abstract-text/8047501/pubmed\" id=\"8047501\" target=\"_blank\">",
"        8047501",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Field JM, Hazinski MF, Sayre MR, et al, \"Part 1: Executive Summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2010, 122(18 Suppl 3):640-56.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/59/14261/abstract-text/20956217/pubmed\" id=\"20956217\" target=\"_blank\">",
"        20956217",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kleinman ME, Chameides L, Schexnayder SM, et al, \"Part 14: Pediatric Advanced Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2010, 122(18 Suppl 3):876-908.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/59/14261/abstract-text/20956230/pubmed\" id=\"20956230\" target=\"_blank\">",
"        20956230",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Konduri GG, Garcia DC, Kazzi NJ, et al, &ldquo;Adenosine Infusion Improves Oxygenation in Term Infants With Respiratory Failure,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1996, 97(3):295-300.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/59/14261/abstract-text/8604260 /pubmed\" id=\"8604260 \" target=\"_blank\">",
"        8604260",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      McIntosh-Yellin NL, Drew BJ, and Scheinman MM, &ldquo;Safety and Efficacy of Central Intravenous Bolus Administration of Adenosine for Termination of Supraventricular Tachycardia,&rdquo;",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 1993, 22(3):741-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/59/14261/abstract-text/8354807 /pubmed\" id=\"8354807 \" target=\"_blank\">",
"        8354807",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Neumar RW, Otto CW, Link MS, et al, \"Part 8: Adult Advanced Cardiovascular Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2010, 122(18 Suppl 3):729-67.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/59/14261/abstract-text/20956224/pubmed\" id=\"20956224\" target=\"_blank\">",
"        20956224",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Paul T and Pfammatter JP, &ldquo;Adenosine: An Effective and Safe Antiarrhythmic Drug in Pediatrics,&rdquo;",
"      <i>",
"       Pediatr Cardiol",
"      </i>",
"      , 1997, 18(2):118-26.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/59/14261/abstract-text/9049125 /pubmed\" id=\"9049125 \" target=\"_blank\">",
"        9049125",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sherwood MC, Lau KC, and Sholler GF, &ldquo;Adenosine in the Management of Supraventricular Tachycardia in Children,&rdquo;",
"      <i>",
"       J Paediatr Child Health",
"      </i>",
"      , 1998, 34(1):53-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/59/14261/abstract-text/9568942/pubmed\" id=\"9568942\" target=\"_blank\">",
"        9568942",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Till J, Shinebourne EA, Rigby ML, et al, &ldquo;Efficacy and Safety in the Treatment of Supraventricular Tachycardia in Infants and Children,&rdquo;",
"      <i>",
"       Br Heart J",
"      </i>",
"      , 1989, 62(3):204-11.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/59/14261/abstract-text/2789912/pubmed\" id=\"2789912\" target=\"_blank\">",
"        2789912",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Zeigler V, &ldquo;Adenosine in the Pediatric Population: Nursing Implications,&rdquo;",
"      <i>",
"       Pediatr Nurs",
"      </i>",
"      , 1991, 17(6):600-2.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?13/59/14261/abstract-text/1754289/pubmed\" id=\"1754289\" target=\"_blank\">",
"        1754289",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13258 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-118.195.65.244-76F9A528C7-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_59_14261=[""].join("\n");
var outline_f13_59_14261=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130686\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130687\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050804\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11426611\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050797\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130666\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130651\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050808\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130734\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050800\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050807\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5174500\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130733\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050812\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050796\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050795\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298689\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130660\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130662\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130675\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050803\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050794\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050810\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050811\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1050813\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13258\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13258|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?43/26/44454?source=related_link\">",
"      Adenosine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?3/23/3444?source=related_link\">",
"      Adenosine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_59_14262="Home arm volumeter";
var content_f13_59_14262=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F54531&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F54531&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 612px\">",
"   <div class=\"ttl\">",
"    How to construct and use a home arm volumeter",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 592px; height: 435px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A, B) Preparation of parts, (C) assembly, and (D) arm volume measurement procedure, including a longitudinal cross-section view.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Lette, J. A simple and innovative device to measure arm volume at home for patients with lymphedema after breast cancer. J Clin Oncol 2006; 24:5434. Copyright &copy;2006 The American Society of Clinical Oncology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_59_14262=[""].join("\n");
var outline_f13_59_14262=null;
var title_f13_59_14263="Principles of burn reconstruction: Perineum and genitalia";
var content_f13_59_14263=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Principles of burn reconstruction: Perineum and genitalia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/59/14263/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/59/14263/contributors\">",
"     Jorge Leon-Villapalos, MD, FRCS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/59/14263/contributors\">",
"     Peter Dziewulski, MD, FRCS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/59/14263/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/59/14263/contributors\">",
"     Marc G Jeschke, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/59/14263/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/59/14263/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/59/14263/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H34613251\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Burns to the perineum and genitalia are an uncommon, but devastating, injury [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/1\">",
"     1",
"    </a>",
"    ]. Burns to these areas generally occur in conjunction with burns involving other anatomic sites, but may be isolated as in the cases of intentional scalding [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Resuscitation and stabilization of the burned patient are the first priorities, followed by management of the burn wounds.",
"   </p>",
"   <p>",
"    Burns to the perineum and genitalia can potentially impair or destroy function, esthetics, and the ability to maintain proper hygiene. The loss of normal tissue and scarring can result in limitation of movement, pain, disfigurement, and social embarrassment. Surveillance for preservation of genitourinary and sexual function is a component of the treatment plan.",
"   </p>",
"   <p>",
"    The initial management of burns to the perineum and genitalia and reconstruction of the resultant complicated wounds are discussed here. Local treatment and acute management and an overview of reconstruction principles are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29225?source=see_link\">",
"     \"Local treatment of burns: Topical antimicrobial agents and dressings\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/10/44201?source=see_link\">",
"     \"Emergency care of moderate and severe thermal burns in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link\">",
"     \"Principles of burn reconstruction: Overview of surgical procedures\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/53/17242?source=see_link\">",
"     \"Emergency care of moderate and severe thermal burns in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34613803\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Burns to the perineum and genitalia occur in approximately 3 to 13 percent of all patients sustaining burns [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Isolated burns to the perineum",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    genitalia are rare, particularly in females [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/1,4,6-8\">",
"     1,4,6-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Isolated burns in children warrant an evaluation for possible child abuse and a clear etiology of the burn should be established [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/2,3,5\">",
"     2,3,5",
"    </a>",
"    ]. Child protection issues are an integral part of the management of the burned child. In a retrospective review of 78 children with perineal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    genital burns, child abuse was the cause of burn injury in 46 percent of boys and 48 percent of girls [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=see_link&amp;anchor=H13#H13\">",
"     \"Physical abuse in children: Epidemiology and clinical manifestations\", section on 'Burns'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=see_link\">",
"     \"Physical abuse in children: Diagnostic evaluation and management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/5/35927?source=see_link\">",
"     \"Child abuse: Social and medicolegal issues\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The global epidemiology of burns is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/19/23865?source=see_link\">",
"     \"Epidemiology of burn injuries globally\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12784924\">",
"    <span class=\"h1\">",
"     CAUSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common causes of perineal and genital burns include scald, flame, chemical, and electrical contact [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/2-4,7\">",
"     2-4,7",
"    </a>",
"    ]. Accidental burns can sometimes be distinguished from intentional burns. Intentional scalds are symmetrical, have distinct upper borders, and may be associated with old fractures or unrelated injuries. In comparison, unintentional perineal burns have irregular borders and depth.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34613314\">",
"    <span class=\"h1\">",
"     INITIAL MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial management of patients with superficial and deep burns to the perineum and genitalia is conservative, including cleansing, gentle gauze debridement of loose burned tissue if present, and coverage with topical antimicrobial agents and dressings. The wound healing rate with conservative measures ranges from approximately 80 to 96 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/1,4,6,7\">",
"     1,4,6,7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29225?source=see_link\">",
"     \"Local treatment of burns: Topical antimicrobial agents and dressings\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients with substantial burns involving the perineum",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    genitalia alone, or including the inguinal or lower truncal areas, the management is more complex. The thighs should be maintained at 15&deg; abduction to facilitate healing and dressing changes [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/1\">",
"     1",
"    </a>",
"    ]. In addition to local topical agents and dressings, the initial management of the extensively burned patient also includes protecting the urethral meatus from obliteration by swelling and protecting the burned skin from urinary and fecal contamination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12785233\">",
"    <span class=\"h2\">",
"     Urinary management",
"    </span>",
"    &nbsp;&mdash;&nbsp;A urethral catheter should be placed in the acute setting to monitor urine output, control urinary continence, and avoid the risk of inability to catheterize the urethra as edema in the perineum develops [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/1\">",
"     1",
"    </a>",
"    ]. A delay in catheterizing the urethra can result in an inability to visualize the structure as edema develops in the preputial skin in males and labial tissue in females, obstructing the meatus. Prophylactic catheterization helps prevent stricture formation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12785244\">",
"    <span class=\"h2\">",
"     Bowel management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fecal contamination of a burn can result in sepsis, delayed wound healing, graft loss, and contracture of scars [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/9\">",
"     9",
"    </a>",
"    ]. Fecal diversion can be managed with the use of either a bowel management system (rectal tube) or a diverting colostomy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/9-13\">",
"     9-13",
"    </a>",
"    ]. Necrotizing infections can occur in contaminated perineal burn wounds. The treatment of necrotizing cellulitis and fasciitis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/22/362?source=see_link\">",
"     \"Necrotizing soft tissue infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <br/>",
"    For most patients, a rectal tube is adequate for fecal diversion. These tubes will only function properly if loose stool material is passed through them, otherwise they become obstructed and may cause fecal impaction. Stool softeners and enemas can be used to maintain loose stools. Two specifically designed intrarectal catheters (ie, Zassi Bowel Management System&reg; and the Flexi-Seal&trade; Fecal Management System) are safe and effective in managing fecal diversion without skin graft loss or a colostomy, but they may also cause anal ulceration and sphincter atony [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/9,10,13\">",
"     9,10,13",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    In patients with deep perineal burns and in young children [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/12\">",
"     12",
"    </a>",
"    ], we use an early, temporary diverting colostomy when it becomes obvious that the management of the burn wound will require a skin graft. This avoids fecal contamination of the burn site and graft.",
"    <br/>",
"    <br/>",
"    Although a diverting colostomy facilitates perineal burn wound management, we have encountered complications in the acute period that included peri-stomal bowel herniation, difficulties sealing the stoma in the presence of surrounding burned tissue with subsequent bowel content leakage, maceration of the peri-stomal skin, and devitalized bowel in the stoma area. The stoma can be reversed after the burns have healed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12785251\">",
"    <span class=\"h2\">",
"     Debridement and demarcation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sharp debridement is",
"    <strong>",
"     not",
"    </strong>",
"    performed until the burns have been allowed to demarcate. Demarcation of the burn wound, which is the conversion of an apparent superficial wound depth to a deeper burn depth, typically occurs by the third post-burn day [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/14/4326?source=see_link&amp;anchor=H11#H11\">",
"     \"Classification of burns\", section on 'Burn depth'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Acute coverage of deep burns, and superficial burns that do not heal with conservative management, includes sharp debridement of the burn eschar after demarcation and coverage of the site with skin grafts. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link&amp;anchor=H22158166#H22158166\">",
"     \"Principles of burn reconstruction: Overview of surgical procedures\", section on 'Early excision and skin grafting'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34613401\">",
"    <span class=\"h1\">",
"     RECONSTRUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reconstruction of the burn wound serves to restore function and improve esthetics by releasing or excising scar contractures",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    remodeling tissues. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link&amp;anchor=H8044867#H8044867\">",
"     \"Principles of burn reconstruction: Overview of surgical procedures\", section on 'Burn reconstruction procedures'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Reconstruction is typically performed after scar maturation, which can require at least one year to develop after wounds have healed. In some instances, reconstructive procedures are performed sooner, such as stricture formation involving the urethra or perineal scar obstructing the anus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link&amp;anchor=H1883166#H1883166\">",
"     \"Principles of burn reconstruction: Overview of surgical procedures\", section on 'Timing of surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5948287\">",
"    <span class=\"h2\">",
"     Perineum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cicatricial contractures are the most common complication of perineal burns, occurring in approximately one-third of patients with partial or full thickness perineal and genital burns [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/6,16\">",
"     6,16",
"    </a>",
"    ]. The perineal contracture can present as a scar band that extends between the medial thighs and crosses the area between the genitalia and the anus, or as a band that extends between the proximal medial thigh to the perineum [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. These scars can result in perineal obliteration, hip adduction contractures, and limitation of the hip range of motion [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The reconstructive procedure performed depends upon the extensiveness of the scar and availability of unburned tissue for coverage of the defect created by contracture release or scar excision. There is no one optimal approach and the surgeon must make a case by case decision for each patient.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with a limited burn contracture, an excision of the contracture with primary closure of the defect can be performed [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      For patients with moderate contractures, or those for whom a primary wound closure is not possible, the defects can be managed using local trapezoid flaps created from tissues on the inner thighs [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/17\">",
"       17",
"      </a>",
"      ]. These flaps are variations of the transposition z-plasty technique that uses adipocutaneous flaps from neighboring skin to interrupt or realign scars without using a skin graft. When performing this technique using burned skin, caution is advised when mobilizing flaps to avoid flap loss. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/11/11446?source=see_link\">",
"       \"Z-plasty\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For wounds not amenable to primary closure or closure with local trapezoid flaps, the defects created by the contracture excision can be covered with full thickness skin grafts, or partial thickness skin grafts with a dermal regeneration template [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/16\">",
"       16",
"      </a>",
"      ]. A discussion on the advantages and disadvantages of the types of skin grafts is reviewed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link&amp;anchor=H8044867#H8044867\">",
"       \"Principles of burn reconstruction: Overview of surgical procedures\", section on 'Burn reconstruction procedures'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For extensive defects that result from excision of large scars, fasciocutaneous flaps can be used. The groin flap, a fasciocutaneous flap that includes the fascia from the sartorius muscle, is excellent tissue for simultaneous perineal, inguinal, and anal reconstruction [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/19\">",
"       19",
"      </a>",
"      ]. The anterolateral thigh flap, which is located between the rectus femoris and vastus lateralis, has emerged as one of the most versatile reconstructive options for multiple sites. Based on a perforator flap harvest concept, the flap encompasses the advantages of versatility, pliability, and potential for composite tissue replacement [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34613422\">",
"    <span class=\"h2\">",
"     Genitalia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of skin grafts with or without dermal scaffolding material is the most frequent procedure performed for secondary reconstruction of burned genitalia. Other options include fasciocutaneous flaps and variations of the z-plasty technique [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/21-23\">",
"     21-23",
"    </a>",
"    ]. The local flap options described for secondary contractures in the inguinal region also apply to reconstruction of genitalia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=see_link\">",
"     \"Principles of burn reconstruction: Overview of surgical procedures\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/32/15882?source=see_link&amp;anchor=H17954524#H17954524\">",
"     \"Principles of burn reconstruction: Extremities and regional nodal basins\", section on 'Inguinal region'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ingenious methods of splinting to secure the skin graft or flap in place have been created. We use Allevyn&reg; foam [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/24\">",
"     24",
"    </a>",
"    ] for its ease of application and have also used topical negative pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/41/26264?source=see_link&amp;anchor=H17#H17\">",
"     \"Negative pressure wound therapy\", section on 'Skin graft/flap fixation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34613330\">",
"    <span class=\"h3\">",
"     Male",
"    </span>",
"    &nbsp;&mdash;&nbsp;Burns to the male genitalia may cause tissue retraction and scarring, which can result in shaft deformity, inability to achieve normal erections, and meatal obstruction. The goal of reconstruction of the penis and scrotum is to maintain urinary and sexual function and preserve anatomical and esthetic integrity.",
"   </p>",
"   <p>",
"    The medical and functional consequences of a burn involving the male external genitalia depend upon the depth and extent of the burn injury. For deep",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    unhealed burns, sharp debridement of devitalized burned tissue is typically performed. Prior to initiating sharp debridement, the urethra should be protected by inserting an indwelling urinary catheter. The penis should be held under gentle traction and all burned tissue sharply d&eacute;brided. We use a Goulian knife with an",
"    <span class=\"nowrap\">",
"     8/1000",
"    </span>",
"    inch guard; a hydrosurgical technique with the VersaJet&trade; system is an acceptable alternative [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Following sharp debridement of devitalized tissue, reconstruction of the male genitalia can proceed depending on the site involved, extensiveness of the burn, and the availability of unburned skin. The following reconstructive options available:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The scrotum can usually be reconstructed using full thickness skin grafts alone or split thickness skin grafts with a dermal template.",
"     </li>",
"     <li>",
"      If the testicles are exposed as a result of the burn or debridement, they can be transferred to pockets fashioned in the inner thigh. While testicular function is preserved, the cosmetic appearance is relatively poor.",
"     </li>",
"     <li>",
"      Reconstruction of the penis involves release of the burn contracture to prevent foreshortening of the shaft.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      If Buck&rsquo;s fascia is spared (",
"      <a class=\"graphic graphic_figure graphicRef76391 \" href=\"UTD.htm?19/0/19462\">",
"       figure 1",
"      </a>",
"      ), multiple Z-plasties can be performed to release the contracture. If the contracture is excised, the defect created is covered with a full thickness skin graft. Split thickness skin graft alone may result in debilitating, inelastic, and painful hypertrophic scars [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/27\">",
"       27",
"      </a>",
"      ]. If using split thickness grafts, a dermal template should be used to avoid these complications.",
"      <br/>",
"      <br/>",
"      If Buck&rsquo;s fascia is involved, a surgical release of the deformity is performed, and the defect can be covered with a pedicled flap, such as the anterolateral thigh flap [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/22\">",
"       22",
"      </a>",
"      ] or the medial circumflex femoral artery perforator flap [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients with loss of the deeper layers of the penis, such as the corpora cavernosa, or loss of the glans and meatus, require a complex and multidisciplinary approach with urologic expertise. Prosthetics and complex free microvascular flaps to reconstruct a neo-phallus may be necessary, such as a thoracodorsal artery perforator flap [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/28\">",
"       28",
"      </a>",
"      ] or a forearm osteocutaneous flap [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/29\">",
"       29",
"      </a>",
"      ] and full thickness skin grafts to create a urethral tract [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/30\">",
"       30",
"      </a>",
"      ]. &nbsp;",
"     </li>",
"     <li>",
"      Scarring of the prepuce is treated by circumcision [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/4\">",
"       4",
"      </a>",
"      ]. Skin from the circumcision can be used as a full thickness graft to the penile shaft if needed.",
"     </li>",
"     <li>",
"      Complete loss of a penis following a burn is rare and there are few reports available that address reconstruction. The microvascular free tissue transfer of a composite radial forearm fasciocutaneous flap phalloplasty with or without a prosthesis or bone graft is an option to closure and urinary drainage through a large meatomy [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/21,31\">",
"       21,31",
"      </a>",
"      ]. A phalloplasty is a challenging procedure associated with complications that include an urethrocutaneous fistula and hair formation [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/31\">",
"       31",
"      </a>",
"      ]. If a total loss occurs in a child, reconstruction is typically performed at age 6 to 8 years, even though revisions will be necessary as the child reaches puberty, because of the psychologic impact that can affect both the child and the parents [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34613322\">",
"    <span class=\"h3\">",
"     Female",
"    </span>",
"    &nbsp;&mdash;&nbsp;The approach to reconstruction of female genitalia after a burn is based upon case reports and small series of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/8,32\">",
"     8,32",
"    </a>",
"    ]. Release of contractures with z-plasty approach and reconstruction with skin grafts and regional flaps are the most common reconstructive procedures used.",
"   </p>",
"   <p>",
"    The reconstruction of the external genitalia and of the internal vault represents similar challenges to the ones described for male genitalia. The reconstructive options available include [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The vaginal vault is usually reconstructed with regional flaps such as the rectus abdominis, gracilis, or perforator based flaps. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/46/6885?source=see_link&amp;anchor=H11#H11\">",
"       \"Vaginectomy\", section on 'Vaginal reconstruction'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Distortion or destruction of the labia is corrected by release or excision of contractures and reconstruction using local skin flaps or grafts [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/1,8\">",
"       1,8",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      To restore a contour deformity caused by loss of skin and subcutaneous tissue, reconstruction can be performed by using an adjacent skin flap and lipoinjection. An alternative is a local flap based in the pudendal artery axis that provides a more pliable though slightly bulkier form of reconstruction.",
"     </li>",
"     <li>",
"      The defect created by contracture release can be covered with a full thickness skin graft or a split thickness skin graft and dermal regeneration template. The type of graft used depends upon the availability of unburned skin.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H118699830\">",
"    <span class=\"h2\">",
"     Outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is limited information on the outcomes of reconstructive procedures for burns to the perineum and genitalia, at least in part due to the rarity of the burn. A review of 5280 pediatric burn reconstructive procedures identified only 18 children (less than one percent) undergoing a release of a perineal contracture [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14263/abstract/16\">",
"     16",
"    </a>",
"    ]. The initial management of 14 of the 18 patients was conservative with minimal wound debridement, topical antimicrobials, and dressing changes. The other four patients were treated with excision and skin grafts.",
"   </p>",
"   <p>",
"    The mean time from burn to contracture development was 3.8 years (range 3 months to 11 years). The contractures were treated with a local flap (10 patients), incisional release and split-thickness skin grafting (5 patients), primary closure and release (1 patient), and a combination of these procedures (2 patients). A secondary contracture developed in 4 patients between approximately 3 and 5 years after the initial perineal reconstruction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H399645927\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Burns to the perineum and genitalia are uncommon, particularly as isolated events.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The primary goal of managing burns of the perineum is preservation of urinary and fecal continence. The initial management of burns to the perineum and genitalia include cleansing, gentle gauze debridement of loose burned tissue, topical antimicrobial agents, and dressing changes. Urinary catheters, rectal tubes, and or a colostomy (temporary or permanent) can be used to protect the burned perineum from contamination. (See",
"      <a class=\"local\" href=\"#H34613314\">",
"       'Initial management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Burns should demarcate before attempting sharp debridement. (See",
"      <a class=\"local\" href=\"#H34613314\">",
"       'Initial management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Reconstruction of the perineum includes release of scar and coverage with skin grafts alone or with dermal regeneration templates, z-plasty techniques with local trapezoid flaps, or fasciocutaneous flaps. (See",
"      <a class=\"local\" href=\"#H5948287\">",
"       'Perineum'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The reconstructive approach is based upon the extensiveness of the scar and the availability of unburned tissue for reconstruction. Reconstruction of the male genitalia is performed to restore function and esthetics. The scrotum can be reconstructed with skin grafts, the penis with contracture release and coverage with skin grafts or pedicled flaps, depending on the extensiveness of damage (see",
"      <a class=\"local\" href=\"#H34613330\">",
"       'Male'",
"      </a>",
"      above). For complete loss of a penis in children, reconstruction is delayed until puberty. Free tissue transfer with or with without the use of a tubed prosthesis may be required in total loss of the penis to warrant sexual function.",
"     </li>",
"     <li>",
"      Reconstruction of the female genitalia includes release of contractures with z-plasty techniques, skin grafts, and regional flaps. Reconstruction of the vaginal vault can be performed with a flap, such as the rectus abdominus or gracilis flap. (See",
"      <a class=\"local\" href=\"#H34613322\">",
"       'Female'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Huang, T. Management of burn injuries of the perineum. In: Total Burn Care, 3rd edition, Herndon, DN (Eds), Saunders Elsevier, 2007. p.749.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/2\">",
"      Maguire S, Moynihan S, Mann M, et al. A systematic review of the features that indicate intentional scalds in children. Burns 2008; 34:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/3\">",
"      Angel C, Shu T, French D, et al. Genital and perineal burns in children: 10 years of experience at a major burn center. J Pediatr Surg 2002; 37:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/4\">",
"      Michielsen D, Van Hee R, Neetens C, et al. Burns to the genitalia and the perineum. J Urol 1998; 159:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/5\">",
"      Michielsen DP, Lafaire C. Management of genital burns: a review. Int J Urol 2010; 17:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/6\">",
"      Alghanem AA, McCauley RL, Robson MC, et al. Management of pediatric perineal and genital burns: twenty-year review. J Burn Care Rehabil 1990; 11:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/7\">",
"      Michielsen D, Van Hee R, Neetens C, et al. Burns to the genitals and the perineum in children. Br J Urol 1996; 78:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/8\">",
"      Weiler-Mithoff EM, Hassall ME, Burd DA. Burns of the female genitalia and perineum. Burns 1996; 22:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/9\">",
"      Bordes J, Goutorbe P, Asencio Y, et al. A non-surgical device for faecal diversion in the management of perineal burns. Burns 2008; 34:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/10\">",
"      Keshava A, Renwick A, Stewart P, Pilley A. A nonsurgical means of fecal diversion: the Zassi Bowel Management System. Dis Colon Rectum 2007; 50:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/11\">",
"      Nakazawa H, Ito H, Morioka K, et al. The use of temporary diverting colostomy to manage elderly individuals with extensive perineal burns. Burns 2002; 28:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/12\">",
"      Quarmby CJ, Millar AJ, Rode H. The use of diverting colostomies in paediatric peri-anal burns. Burns 1999; 25:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/13\">",
"      Wishin J, Gallagher TJ, McCann E. Emerging options for the management of fecal incontinence in hospitalized patients. J Wound Ostomy Continence Nurs 2008; 35:104.",
"     </a>",
"    </li>",
"    <li>",
"     American Burn Association White Paper: Surgical management of the burn wound and use of skin substitutes. 2009. page 9. www.ameriburn.org/WhitePaperFinal.pdf (Accessed on July 18, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/15\">",
"      Schultz GS, Barillo DJ, Mozingo DW, et al. Wound bed preparation and a brief history of TIME. Int Wound J 2004; 1:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/16\">",
"      Pisarski GP, Greenhalgh DG, Warden GD. The management of perineal contractures in children with burns. J Burn Care Rehabil 1994; 15:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/17\">",
"      Grishkevich VM. Burned perineum reconstruction: a new approach. J Burn Care Res 2009; 30:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/18\">",
"      Grishkevich VM. Postburn perineal obliteration: elimination of perineal, inguinal, and perianal contractures with the groin flap. J Burn Care Res 2010; 31:786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/19\">",
"      McGregor IA, Jackson IT. The groin flap. Br J Plast Surg 1972; 25:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/20\">",
"      Ali RS, Bluebond-Langner R, Rodriguez ED, Cheng MH. The versatility of the anterolateral thigh flap. Plast Reconstr Surg 2009; 124:e395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/21\">",
"      Prakash V. Amputation of the penis due to electrical burn--role of prefabricated urethra in penile reconstruction. Burns 2008; 34:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/22\">",
"      Uygur F, Sever C, Kulahci Y, Giderolu K. Reconstruction of postburn inguinal contractures using the pedicled anterolateral thigh flap. Burns 2009; 35:e3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/23\">",
"      Karsidag S, Akcal A, Sirvan SS, et al. Perineoscrotal reconstruction using a medial circumflex femoral artery perforator flap. Microsurgery 2011; 31:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/24\">",
"      Abela C, Lucas N, McLeod I, Myers S. Protection of skin grafts to the penile shaft using a novel manipulation of Allevyn dressing--case report of an alkali burn. Burns 2006; 32:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/25\">",
"      Shvartsman HS, Langstein H, Worley C, et al. Use of a vacuum-assisted closure device in the treatment of recurrent Paget's disease of the vulva. Obstet Gynecol 2003; 102:1163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/26\">",
"      Yeh CC, Lin YS, Huang KF. Resurfacing of total penile full-thickness burn managed with the Versajet hydrosurgery system. J Burn Care Res 2010; 31:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/27\">",
"      Jaskille AD, Shupp JW, Jeng JC, Jordan MH. Use of Integra in the treatment of third degree burns to the penile shaft: a case series with 6-month follow-up. J Burn Care Res 2009; 30:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/28\">",
"      Lin CT, Chen LW. Using a free thoracodorsal artery perforator flap for phallic reconstruction--a report of surgical technique. J Plast Reconstr Aesthet Surg 2009; 62:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/29\">",
"      Kim SK, Lee KC, Kwon YS, Cha BH. Phalloplasty using radial forearm osteocutaneous free flaps in female-to-male transsexuals. J Plast Reconstr Aesthet Surg 2009; 62:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/30\">",
"      Sasaki K, Nozaki M, Morioka K, Huang TT. Penile reconstruction: combined use of an innervated forearm osteocutaneous flap and big toe pulp. Plast Reconstr Surg 1999; 104:1054.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14263/abstract/31\">",
"      Horton CE, Dean JA. Reconstruction of traumatically acquired defects of the phallus. World J Surg 1990; 14:757.",
"     </a>",
"    </li>",
"    <li>",
"     Abdel-Razek SM. Isolated chemical burns to the genitalia. Annals of Burns and Fire Disasters. vol. XIX, n3, September 2006. www.medbc.com/annals/review/vol_19/num_3/text/vol19n3p148.asp (Accessed on July 20, 2011).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15439 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-197.136.42.3-A295DD27D0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_59_14263=[""].join("\n");
var outline_f13_59_14263=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H399645927\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34613251\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34613803\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12784924\">",
"      CAUSES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34613314\">",
"      INITIAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12785233\">",
"      Urinary management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12785244\">",
"      Bowel management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12785251\">",
"      Debridement and demarcation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34613401\">",
"      RECONSTRUCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5948287\">",
"      Perineum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34613422\">",
"      Genitalia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H34613330\">",
"      - Male",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H34613322\">",
"      - Female",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H118699830\">",
"      Outcomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H399645927\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/15439\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15439|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/0/19462\" title=\"figure 1\">",
"      Penis anatomy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/5/35927?source=related_link\">",
"      Child abuse: Social and medicolegal issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/14/4326?source=related_link\">",
"      Classification of burns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/53/17242?source=related_link\">",
"      Emergency care of moderate and severe thermal burns in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/10/44201?source=related_link\">",
"      Emergency care of moderate and severe thermal burns in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/19/23865?source=related_link\">",
"      Epidemiology of burn injuries globally",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29225?source=related_link\">",
"      Local treatment of burns: Topical antimicrobial agents and dressings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/22/362?source=related_link\">",
"      Necrotizing soft tissue infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/41/26264?source=related_link\">",
"      Negative pressure wound therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=related_link\">",
"      Physical abuse in children: Diagnostic evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=related_link\">",
"      Physical abuse in children: Epidemiology and clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/32/15882?source=related_link\">",
"      Principles of burn reconstruction: Extremities and regional nodal basins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20346?source=related_link\">",
"      Principles of burn reconstruction: Overview of surgical procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/46/6885?source=related_link\">",
"      Vaginectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/11/11446?source=related_link\">",
"      Z-plasty",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_59_14264="Urinary tract infections in newborns";
var content_f13_59_14264=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Urinary tract infections in newborns",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/59/14264/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/59/14264/contributors\">",
"     Donough J O'Donovan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/59/14264/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/59/14264/contributors\">",
"     Tej K Mattoo, MD, DCH, FRCP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/59/14264/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/59/14264/contributors\">",
"     Leonard E Weisman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/59/14264/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/59/14264/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/59/14264/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 2, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinary tract infection (UTI) in newborns frequently is associated with bacteremia and may result in long-term complications [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Newborns with UTI should be evaluated for associated systemic infection and anatomic or functional abnormalities of the urinary tract.",
"   </p>",
"   <p>",
"    The epidemiology, pathogenesis, clinical features, diagnosis, and management of UTIs in newborns will be reviewed here. UTIs in older infants are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/40/21129?source=see_link\">",
"     \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/1/27674?source=see_link\">",
"     \"Acute management, imaging, and prognosis of urinary tract infections in infants and children older than one month\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In normal term newborns, the incidence of bacteriuria determined by prospective bladder urine collection (suprapubic aspiration) is 0.1 to 1 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/2-9\">",
"     2-9",
"    </a>",
"    ]. In one study, for example, \"clean catch\" urine samples were collected in 1460 newborns at three to six days of age. If the level of bacteriuria exceeded predetermined criteria, suprapubic bladder aspiration was performed. Significant bacteriuria was detected by this method in 0.95 percent of the group (11 males and 3 females) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of significant bacteriuria may be higher in high-risk newborns. As an example, in a report of 1128 term and post-term infants admitted to a neonatal intensive care unit in Switzerland, significant bacteriuria was detected by suprapubic bladder aspiration in 2.8 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/3\">",
"     3",
"    </a>",
"    ]. In premature infants, the incidence of bacteriuria is 2 to 6 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/3,4,7,8\">",
"     3,4,7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    UTI occurs in 1.5 to 5 times as many males as females in the neonatal period and is higher in uncircumcised than circumcised males [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/3-6,10-12\">",
"     3-6,10-12",
"    </a>",
"    ]. The incidence decreases in boys and increases in girls during the first six months after birth [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/13\">",
"     13",
"    </a>",
"    ]. As a result, UTI is approximately three times more common in females than males by one year of age. The higher incidence in neonatal mal",
"1ff8",
"es also appears to occur in preterm infants, although data are limited [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/4,9,14\">",
"     4,9,14",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Pathogenesis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    UTI typically presents in the second week after birth in term infants and somewhat later in preterm infants [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/3,9-11\">",
"     3,9-11",
"    </a>",
"    ]. This infection is an unusual occurrence during the first three days after birth [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most urinary tract infections (UTIs) in infants are caused by Gram negative aerobic bacilli known as Enterobacteriaceae. Escherichia coli (E. coli) is the most common organism isolated in the newborn period, accounting for up to 80 percent of infections in most large series [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/3,6,17-19\">",
"     3,6,17-19",
"    </a>",
"    ]. This pathogen also is the most frequent cause of UTI at all ages. Other Enterobacteriaceae, which can produce UTI, include: Klebsiella, Enterobacter, Citrobacter, Proteus, Providencia, Morganella, Serratia, and Salmonella species. Staphylococcus and Enterococcus species are the most common Gram positive organisms isolated, but they occur distinctly less frequently than do Gram negative pathogens.",
"   </p>",
"   <p>",
"    Fungal infections of the urinary tract, predominantly Candida species, occur commonly in premature infants. In one report of 60 UTIs in 57 hospitalized newborns, Candida species accounted for 42 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/20\">",
"     20",
"    </a>",
"    ]. Gestational (26 versus 28 weeks) and postnatal (34 versus 79 days) ages were lower in infants with Candida compared with bacterial infections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Virulence factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several virulence factors in E. coli account for the propensity of this organism to cause UTI, especially when the urinary tract is anatomically normal [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/46/16102?source=see_link\">",
"     \"Bacterial adherence and other virulence factors for urinary tract infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bacterial attachment to uroepithelial cells requires the presence of bacterial fimbriae or other surface adhesion systems. In some bacterium, such as E. Coli, attachment is facilitated by adhesins located on the bacterial fimbriae (also called pili) and bacterial surface that recognize epithelial cell surface binding sites. Other factors that affect the virulence of E. coli include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The presence of flagella, which are necessary for motility.",
"     </li>",
"     <li>",
"      Production of a hemolysin, which induces formation of pores in the cell membrane, and aerobactin, a siderophore necessary for iron uptake from the iron-poor environment of the urinary tract.",
"     </li>",
"     <li>",
"      Resistance to plasma bactericidal properties.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most urinary tract infections (UTIs) in newborns represent upper tract infection (pyelonephritis) rather than simple cystitis. Accompanying bacteremia is common. Ascending infection is important and is associated with urinary tract abnormalities and lack of circumcision in males. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41705?source=see_link\">",
"     \"Neonatal circumcision: Risks and benefits\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Hematogenous infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hematogenous spread of infection has been thought to be responsible for neonatal UTI because of the frequent association between upper tract infection and bacteremia. However, the microbiology of these infections and the high incidence of urinary tract abnormalities raise the question of whether neonatal UTI truly arises from hematogenous spread from a remote source (eg, intravascular catheter), or is due to an ascending urinary tract infection with an associated bacteremia.",
"   </p>",
"   <p>",
"    Approximately one-third of neonates with UTI have bacteremia with the same organism, and a substantial proportion also have meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/11,17,21-23\">",
"     11,17,21-23",
"    </a>",
"    ]. The risk of associated bacteremia decreases with increasing postnatal age. As an example, in a review of 100 infants (who were considered normal at the time of discharge from the nursery) with UTI, sepsis occurred in 31, 21, and 5 percent of infants less than one, one to three, and more than three months of age, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The association between UTI and bacteremia is also common in preterm infants. In a retrospective review of data from 322 neonatal intensive care units managed by the Pediatrix Medical Group from 1997 to 2010, 13 percent of patients (who were &lt;121 days of age) with a UTI also had a positive blood culture collected within three days with the same pathogenic organism [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/24\">",
"     24",
"    </a>",
"    ]. In this cohort, infants developed UTI at a mean age of 42 days. Patients with concordant infection (same organism isolated from urine and blood cultures) were more likely to be less than 26 weeks gestational age (37 versus 26 percent) and receive mechanical ventilation on the first day of life (68 versus 57 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Urinary tract abnormalities",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Full-term infants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 30 to 50 percent of term newborns with UTI have urinary tract abnormalities, of which vesicoureteric reflux (VUR) is most common [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/17-22\">",
"     17-22",
"    </a>",
"    ]. This incidence was illustrated in one report of 45 males younger than eight weeks old with UTI; urinary tract abnormalities were observed in 22; 19 had VUR, 2 had VUR and another problem (double collecting system and posterior urethral valves), and 1 had ureteropelvic junction stricture [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/10/3242?source=see_link\">",
"     \"Presentation, diagnosis, and clinical course of vesicoureteral reflux\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other lesions found in infants with UTI include obstructive abnormalities (eg, ureteropelvic junction or ureterovesical junction obstruction, posterior urethral valves), malformations (eg, ectopic ureter), or renal conditions (eg, polycystic diseases, renal dysplasia).",
"   </p>",
"   <p>",
"    Urinary tract abnormalities may contribute to UTI by several mechanisms, including inadequate urine flow, incomplete emptying of the bladder, and incompetent anatomic junctions that permit reflux of contaminated urine. As a result, infection can occur with organisms lacking virulence factors. In a study of children with UTI, for example, infections caused by P-fimbriated stains of E. coli were less common with than without VUR (36 versus 71 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Preterm",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast, the prevalence of major anatomical abnormalities appears to be low in preterm infants with UTI. This was illustrated by a retrospective study of preterm infants with UTI who were less than two months of age and hospitalized in a neonatal intensive care unity (NICU) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264",
"1ff8",
"/abstract/26\">",
"     26",
"    </a>",
"    ]. Major renal abnormalities were detected in 5 of 118 infants (4 percent) who had at least one imaging study, and included grade 3 hydronephrosis, grade III vesicoureteral reflux, renal dysplasia, unilateral agenesis, and a horseshoe kidney. The most common identified causative organism was coagulase-negative Staphylococcus (28 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Uncircumcised males",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of UTI is increased in uncircumcised males. In one report of approximately 136,000 boys in United States Army hospitals, the frequency of UTI during the first month after birth was significantly higher in uncircumcised than circumcised infants (0.19 versus 0.02 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/21\">",
"     21",
"    </a>",
"    ]. The increased incidence in uncircumcised males persists during the first year after birth [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41705?source=see_link\">",
"     \"Neonatal circumcision: Risks and benefits\"",
"    </a>",
"    and",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?1/5/1107?source=see_link\">",
"     \"Patient information: Circumcision in baby boys (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The higher incidence of UTI in uncircumcised males is related to an increased rate of bacterial colonization and enhanced bacterial adherence [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]. In one study, E. coli and other Gram negative uropathogenic organisms were cultured more frequently from the urethras of uncircumcised than from those of circumcised boys, and bacterial colony counts were higher [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/29\">",
"     29",
"    </a>",
"    ]. In another report, uropathogenic organisms preferentially adhered to the mucosal inner surface of the foreskin rather than the keratinized external surface, increasing the likelihood of ascending infection [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Term infants",
"    </span>",
"    &nbsp;&mdash;&nbsp;The signs and symptoms of urinary track infection (UTI) in newborns are nonspecific. Infants can have lethargy, irritability, tachypnea, or cyanosis, and may appear acutely ill.",
"   </p>",
"   <p>",
"    The most common clinical findings are [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/3,6,10,11\">",
"     3,6,10,11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Fever (20 to 40 percent)",
"     </li>",
"     <li>",
"      Failure to thrive (15 to 43 percent)",
"     </li>",
"     <li>",
"      Jaundice (3 to 41 percent)",
"     </li>",
"     <li>",
"      Vomiting (9 to 41 percent)",
"     </li>",
"     <li>",
"      Loose stools (3 to 5 percent)",
"     </li>",
"     <li>",
"      Poor feeding (3 to 5 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The hyperbilirubinemia that occurs with UTI typically is conjugated and related to cholestasis, although it may be unconjugated. Jaundice may be the first sign of UTI in some infants. In one report, UTI was diagnosed in 12 (7.5 percent) of 160 asymptomatic jaundiced infants less than eight weeks of age who presented to an emergency department [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/32\">",
"     32",
"    </a>",
"    ]. Onset of jaundice after eight days was more common in infants with positive compared with negative cultures (50 versus 10 percent). Other findings that occur less commonly include abdominal distension resulting from ileus or enlarged kidneys caused by hydronephrosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/60/24519?source=see_link\">",
"     \"Approach to neonatal cholestasis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/3/39992?source=see_link\">",
"     \"Pathogenesis and etiology of unconjugated hyperbilirubinemia in the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Preterm infants",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of UTI in preterm infants are similar to those of term infants, with the addition of apnea and hypoxia. This was illustrated in a study of 56 preterm infants with UTI from a retrospective cohort of 6198 preterm infants (0.9 percent) born between 1995 and 2003 from a single Israeli neonatal intensive care unit (NICU) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/33\">",
"     33",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Feeding intolerance (62 percent)",
"     </li>",
"     <li>",
"      Apnea and bradycardia (45 percent)",
"     </li>",
"     <li>",
"      Lethargy (30 percent)",
"     </li>",
"     <li>",
"      Tachypnea (30 percent)",
"     </li>",
"     <li>",
"      Abdominal distension (12 percent)",
"     </li>",
"     <li>",
"      Hypoxia with documented oxygen desaturation (12 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In this report, risk factors for UTI in preterm infants included male gender, birth weight below 1500 g, receipt of total parental nutrition, and a peripheral intravenous line. Breastfeeding was associated with a decreased risk for UTI. Blood cultures were also positive in 14 patients (25 percent). The most common causative organism for UTI was Klebsiella followed by Escherichia coli.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnosis of urinary tract infection (UTI) is based upon culture of an organism from an appropriately collected specimen of urine. An abnormal urinalysis must be confirmed by a positive urine culture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Urine collection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specimens should be obtained by suprapubic bladder aspiration or catheterization. Collections in a bag frequently are contaminated, and a midstream clean catch specimen is impractical in newborns.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Suprapubic aspiration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Suprapubic aspiration of the bladder urine is the most reliable technique to identify bacteriuria [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/34\">",
"     34",
"    </a>",
"    ]. The technique is simple, relatively safe, and causes minimum discomfort.",
"   </p>",
"   <p>",
"    The procedure should be performed in infants who have a palpable bladder and who have not voided recently. After cleaning the suprapubic area with an antiseptic solution, a 23- or 25-gauge needle is inserted perpendicular to the baby, approximately one centimeter above the pubic symphysis. In one report, ultrasound guidance improved the yield of urine compared with unguided aspiration (96 versus 60 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/35\">",
"     35",
"    </a>",
"    ]. Any growth of urinary pathogens is significant.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Bladder catheterization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bladder catheterization is an alternative to suprapubic collection. Bacterial contamination resulting from incomplete cleansing of the perineal area or prepuce renders this technique less reliable than suprapubic aspiration. In a study comparing catheterization to bladder aspiration in febrile infants younger than one year of age, catheterization cultures with &gt;1000",
"    <span class=\"nowrap\">",
"     CFU/mL",
"    </span>",
"    had a sensitivity and specificity of 95 and 99 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Urinalysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A urinalysis typically includes microscopic assessment of the number of white blood cells (WBC) per high powered field (hpf) of a centrifuged specimen of urine. However, the sensitivity, specificity, and positive predictive value of pyuria, defined as &ge;5 WBC per hpf, to correlate with a positive urine culture are low [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/37,38\">",
"     37,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prediction of UTI is improved when hemocytometer WBC",
"1ff8",
" counts are performed on uncentrifuged specimens, as recommended in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/39\">",
"     39",
"    </a>",
"    ]. In a study of febrile (rectal temperature &gt;38&ordm;C) infants younger than eight weeks of age in which UTI occurred in 13.6 percent, hemocytometer WBC",
"    <span class=\"nowrap\">",
"     &ge;10/microL",
"    </span>",
"    had a higher sensitivity (82 versus 59 percent) compared with standard urinalysis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Dipsticks that detect the presence of leukocyte esterase and nitrite are available commercially; the former corresponds to significant pyuria and the latter to Enterobacteriaceae, which convert urinary nitrate to nitrite. In adults, the dipstick has a sensitivity and specificity of 95 and 75 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/40\">",
"     40",
"    </a>",
"    ]. The positive predictive value is 30 to 40 percent (when tested in patients suspected of possible UTI), and the negative predictive value is 99 percent. Dipsticks may be used for rapid and easy screening. However, urine culture must always be performed in an infant in whom UTI is suspected [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/41,42\">",
"     41,42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The presence of organisms on a Gram stain of 0.01 mL of unspun urine correlates with subsequent growth in a urine culture of &gt;10(5) CFU in adults. This density of bacteria rarely is recovered in a urine culture from neonates. Even if urine Gram staining were readily available, it rarely would be performed in infants for this reason.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Sepsis evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, approximately one-third of newborns with UTI have an accompanying bacteremia, and some have meningitis. Thus, a blood culture should be obtained in all infants in whom UTI is suspected. Infants at increased risk for fungal infection should be evaluated for disseminated disease. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Hematogenous infection'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In addition, clinicians should have a low threshold to perform a lumbar puncture, as approximately 1 percent of infants with UTI have bacterial meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. In particular, ill-appearing infants or those with a fever are at increased risk for meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/45\">",
"     45",
"    </a>",
"    ]. In these patients, a lumbar puncture should be performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment with intravenous broad-spectrum antimicrobial agents should be initiated as soon as cultures of urine, blood, and cerebrospinal fluid (if indicated) have been obtained.",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"     Ampicillin",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"     gentamicin",
"    </a>",
"    provide coverage for the most common bacterial pathogens.",
"   </p>",
"   <p>",
"    However, with increasing reports of resistant organisms local surveillance of pathogens and antibiotic susceptibility patterns may be important to determine appropriate initial antibiotic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Experts vary in their dosing recommendations. In term infants younger than seven days old with birth weights greater than 2 kg, the American Academy of Pediatrics Red Book recommends",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"     ampicillin",
"    </a>",
"    (50",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose every eight hours intravenously) and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"     gentamicin",
"    </a>",
"    (2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose every 12 hours intravenously) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/47\">",
"     47",
"    </a>",
"    ]. Other experts use once-daily gentamicin dosing (4",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose every 24 hours intravenously) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/48\">",
"     48",
"    </a>",
"    ].",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     Vancomycin",
"    </a>",
"    (10 to 15",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose every12 hours intravenously for infants &lt;7 days and every eight hours thereafter) usually is substituted for ampicillin in infants with later onset infections to provide empiric coverage for hospital-associated infections, including coagulase-negative staphylococci, Staphylococcus aureus, and Enterococcus species.",
"   </p>",
"   <p>",
"    If meningitis is suspected, the higher doses of antibiotics must be used, pending the results of cultures [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/47\">",
"     47",
"    </a>",
"    ]. Antibiotics should be tailored when the results of the cultures and the antimicrobial susceptibilities become available.",
"   </p>",
"   <p>",
"    Sterilization of the urine should occur within 48 hours of treatment with the appropriate antimicrobial agent. Optimally, it should be confirmed by repeating the urine culture at that time. If bacteriuria persists despite appropriate therapy, the urinary tract and other sites should be investigated to determine a potential reservoir of infection.",
"   </p>",
"   <p>",
"    There are no currently available data that unequivocally lays out the optimal approach to treating urinary tract infection (UTI) in the neonate. As a result, management is based on expert opinion. In our center, the duration of antibiotic therapy is 10 to 14 days for newborns with uncomplicated bacterial UTI. We complete the treatment course in newborns with intravenous antibiotics, although older infants often are switched to oral antibiotics after clinical improvement based on the judgement of the individual clinician. Longer treatment is needed for fungal infections.",
"   </p>",
"   <p>",
"    Conventional teaching holds that the urine culture should be repeated two to three days following the completion of treatment. However, because suprapubic aspiration or repeat catheterization would be required, it often is omitted if the patient is clinically stable. Antibiotic prophylaxis with low-dose",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/49/34583?source=see_link\">",
"     amoxicillin",
"    </a>",
"    (15 to 20",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day PO) is started until a radiographic evaluation has been performed to detect urinary tract abnormalities. Continuation of this prophylaxis depends upon the results of imaging studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     RADIOGRAPHIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the high prevalence of urinary tract abnormalities, radiographic evaluation is performed in all newborns with urinary tract infection (UTI). This evaluation includes ultrasonography to detect structural abnormalities and a voiding cystourethrogram (VCUG) to identify reflux.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Renal ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;A renal ultrasound should be obtained after antibiotic treatment is initiated and the infant's clinical condition has stabilized. This examination will demonstrate the presence, position, and size of the kidney; the size and thickness of the bladder; dilation of the collecting system; and any structural abnormalities. Ultrasound may identify echogenic fungal material or stones. However, a normal ultrasound examination does",
"    <strong>",
"     not",
"    </strong>",
"    exclude vesicoureteric reflux (VUR) or renal scarring.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Voiding cystourethrogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;A VCUG is performed to detect VUR. If not performed earlier, repeat urine culture is performed at the time of this procedure. The procedure usually is performed three to six weeks after antibiotic treatment is completed, although it can b",
"1ff8",
"e performed as soon as the urine is sterilized. Performing VCUG should not be delayed in infants who have abnormalities detected on ultrasonography. Earlier examination also may be indicated in infants with abnormalities detected on antenatal ultrasound examination.",
"   </p>",
"   <p>",
"    Radionuclide cystography (RNC) is used by some clinicians as an alternative to VCUG in children, although data are not available in newborns [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/34\">",
"     34",
"    </a>",
"    ]. However, VCUG with fluoroscopy characterizes reflux better than does RNC. VCUG also detects intrarenal reflux and provides functional and anatomic information about the bladder and urethra that cannot be obtained by RNC. For these reasons, VCUG is the preferred technique. Alternative procedures that avoid radiation exposure, such as contrast-enhanced sonography, remain under investigation [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Other imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal cortical scintigraphy (with 99 m Tc-DMSA) and enhanced computed tomography may be used to identify renal scarring and acute changes due to pyelonephritis. Cortical scintigraphy is more sensitive than is ultrasonography to detect renal changes [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/50\">",
"     50",
"    </a>",
"    ]. It may be considered if renal damage is suggested by ultrasonography or as part of follow-up evaluation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many children with urinary tract infection (UTI) develop renal scarring, and newborns also are likely at risk for this complication. Renal scarring may result in hypertension and chronic renal disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/1/27674?source=see_link&amp;anchor=H20#H20\">",
"     \"Acute management, imaging, and prognosis of urinary tract infections in infants and children older than one month\", section on 'Prognosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In one study, renal scars were documented by follow-up scintigraphy in 40 percent of infants with UTI at less than one year of age [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/51\">",
"     51",
"    </a>",
"    ]. In another report by the same authors, few infants in this age group with renal scarring had VUR [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/52\">",
"     52",
"    </a>",
"    ]. Nephropathy also can be present at birth in infants with severe reflux seen on prenatal ultrasonography without UTI [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/53,54\">",
"     53,54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neonatal UTI may impair renal growth. In one study, 22 children who had UTI before reaching one month of age were followed for 12 to 21 years [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14264/abstract/55\">",
"     55",
"    </a>",
"    ]. Renal growth was decreased in patients with and without reflux at approximately four years after the UTI, although renal size tended to become normal later.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H776291741\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinary tract infection (UTI) in newborns frequently is associated with bacteremia and may result in long-term complications.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In normal term newborns, the incidence of bacteriuria determined by prospective bladder urine collection (suprapubic aspiration) is 0.1 to 1 percent. The incidence is higher in premature infants and uncircumcised males. UTI is uncommon in the first three days after birth and generally presents in the second week after birth in term infants and somewhat later in preterm infants. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Escherichia coli is the most common organism isolated in the newborn period, accounting for up to 80 percent of UTIs in large case series. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most UTIs in newborns represent upper tract infection (pyelonephritis) rather than simple cystitis. Pathogenesis includes either hematogenous spread secondary to bacteremia or ascending infection, especially in infants with urinary tract abnormalities or uncircumcised males. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is not a consistent and common presentation for neonatal UTIs. The signs and symptoms of neonatal UTIs are numerous and nonspecific. Manifestations are similar in term and preterm infants, and the addition of apnea and hypoxia are more frequently found in preterm infants. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnosis of UTI is based upon culture of an organism from either a specimen obtained by suprapubic bladder aspiration or catheterization. Because of the associated risk of bacteremia, blood cultures should be obtained in all infants in whom UTI is suspected, and culture of the cerebrospinal fluid (CSF) should be strongly considered. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment with intravenous broad-spectrum antimicrobial agents (eg, combination of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/38/38503?source=see_link\">",
"       ampicillin",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/48/37632?source=see_link\">",
"       gentamicin",
"      </a>",
"      ) should be initiated as soon as cultures of urine, blood, and CSF (if indicated) have been obtained. Changes in antibiotic therapy are based on culture results including antimicrobial susceptibilities. In our practice, we treat uncomplicated neonatal bacterial UTI with a 10 to 14 day course of intravenous antibiotic therapy. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Because of the high prevalence of urinary tract abnormalities, radiographic evaluation is performed in all newborns with UTI. This evaluation includes ultrasonography to detect structural abnormalities and a voiding cystourethrogram (VCUG) to identify reflux. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Radiographic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Similar to older children, newborns with upper tract UTIs also are at risk for developing renal scarring. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Outcome'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/1\">",
"      Jakobsson B, Jacobson SH, Hjalm&aring;s K. Vesico-ureteric reflux and other risk factors for renal damage: identification of high- and low-risk children. Acta Paediatr Suppl 1999; 88:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/2\">",
"      Jacobson SH, Ekl&ouml;f O, Eriksson CG, et al. Development of hypertension and uraemia after pyelonephritis in childhood: 27 year follow up. BMJ 1989; 299:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/3\">",
"      Maherzi M, Guignard JP, Torrado A. Urinary tract infection in high-risk newborn infants. Pediatrics 1978; 62:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/4\">",
"      Edelmann CM Jr, Ogwo JE, Fine BP, Martinez AB. The prevalence of bacteriuria in full-term and premature newborn infants. J Pediatr 1973; 82:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/5\">",
"      Abbott GD. Neonatal bacteriuria: a prospective study in 1,460 infants. Br Med J 1972; 1:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/6\">",
"      Bergstr&ouml;m T, Larson H, Lincoln K, Wi",
"1ff8",
"nberg J. Studies of urinary tract infections in infancy and childhood. XII. Eighty consecutive patients with neonatal infection. J Pediatr 1972; 80:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/7\">",
"      Zies L, Ramirez J, Jannach JR. Incidence of bacteriuria in the premature infant as determined by suprapubic aspiration. J Fla Med Assoc 1968; 55:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/8\">",
"      Moncrieff M, Bamford M, Benson J, Bodden J. Asymptomatic bacteriuria in healthy preterm babies. Arch Dis Child 1980; 55:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/9\">",
"      Eliakim A, Dolfin T, Korzets Z, et al. Urinary tract infection in premature infants: the role of imaging studies and prophylactic therapy. J Perinatol 1997; 17:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/10\">",
"      Drew JH, Acton CM. Radiological findings in newborn infants with urinary infection. Arch Dis Child 1976; 51:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/11\">",
"      Littlewood JM. 66 infants with urinary tract infection in first month of life. Arch Dis Child 1972; 47:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/12\">",
"      Singh-Grewal D, Macdessi J, Craig J. Circumcision for the prevention of urinary tract infection in boys: a systematic review of randomised trials and observational studies. Arch Dis Child 2005; 90:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/13\">",
"      Jakobsson B, Esbj&ouml;rner E, Hansson S. Minimum incidence and diagnostic rate of first urinary tract infection. Pediatrics 1999; 104:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/14\">",
"      Airede AI. Urinary-tract infections in African neonates. J Infect 1992; 25:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/15\">",
"      DiGeronimo RJ. Lack of efficacy of the urine culture as part of the initial workup of suspected neonatal sepsis. Pediatr Infect Dis J 1992; 11:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/16\">",
"      Visser VE, Hall RT. Urine culture in the evaluation of suspected neonatal sepsis. J Pediatr 1979; 94:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/17\">",
"      Ginsburg CM, McCracken GH Jr. Urinary tract infections in young infants. Pediatrics 1982; 69:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/18\">",
"      Honkinen O, Lehtonen OP, Ruuskanen O, et al. Cohort study of bacterial species causing urinary tract infection and urinary tract abnormalities in children. BMJ 1999; 318:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/19\">",
"      Ismaili K, Lolin K, Damry N, et al. Febrile urinary tract infections in 0- to 3-month-old infants: a prospective follow-up study. J Pediatr 2011; 158:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/20\">",
"      Phillips JR, Karlowicz MG. Prevalence of Candida species in hospital-acquired urinary tract infections in a neonatal intensive care unit. Pediatr Infect Dis J 1997; 16:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/21\">",
"      Wiswell TE, Geschke DW. Risks from circumcision during the first month of life compared with those for uncircumcised boys. Pediatrics 1989; 83:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/22\">",
"      Goldman M, Lahat E, Strauss S, et al. Imaging after urinary tract infection in male neonates. Pediatrics 2000; 105:1232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/23\">",
"      Byington CL, Enriquez FR, Hoff C, et al. Serious bacterial infections in febrile infants 1 to 90 days old with and without viral infections. Pediatrics 2004; 113:1662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/24\">",
"      Downey LC, Benjamin DK Jr, Clark RH, et al. Urinary tract infection concordance with positive blood and cerebrospinal fluid cultures in the neonatal intensive care unit. J Perinatol 2013; 33:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/25\">",
"      Lomberg H, Hellstr&ouml;m M, Jodal U, et al. Virulence-associated traits in Escherichia coli causing first and recurrent episodes of urinary tract infection in children with or without vesicoureteral reflux. J Infect Dis 1984; 150:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/26\">",
"      Nowell L, Moran C, Smith PB, et al. Prevalence of renal anomalies after urinary tract infections in hospitalized infants less than 2 months of age. J Perinatol 2010; 30:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/27\">",
"      Wiswell TE, Hachey WE. Urinary tract infections and the uncircumcised state: an update. Clin Pediatr (Phila) 1993; 32:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/28\">",
"      Zorc JJ, Levine DA, Platt SL, et al. Clinical and demographic factors associated with urinary tract infection in young febrile infants. Pediatrics 2005; 116:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/29\">",
"      Wiswell TE, Miller GM, Gelston HM Jr, et al. Effect of circumcision status on periurethral bacterial flora during the first year of life. J Pediatr 1988; 113:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/30\">",
"      Glennon J, Ryan PJ, Keane CT, Rees JP. Circumcision and periurethral carriage of Proteus mirabilis in boys. Arch Dis Child 1988; 63:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/31\">",
"      Fussell EN, Kaack MB, Cherry R, Roberts JA. Adherence of bacteria to human foreskins. J Urol 1988; 140:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/32\">",
"      Garcia FJ, Nager AL. Jaundice as an early diagnostic sign of urinary tract infection in infancy. Pediatrics 2002; 109:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/33\">",
"      Levy I, Comarsca J, Davidovits M, et al. Urinary tract infection in preterm infants: the protective role of breastfeeding. Pediatr Nephrol 2009; 24:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/34\">",
"      Downs SM. Technical report: urinary tract infections in febrile infants and young children. The Urinary Tract Subcommittee of the American Academy of Pediatrics Committee on Quality Improvement. Pediatrics 1999; 103:e54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/35\">",
"      Kiernan SC, Pinckert TL, Keszler M. Ultrasound guidance of suprapubic bladder aspiration in neonates. J Pediatr 1993; 123:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/36\">",
"      Bonadio WA. Urine culturing technique in febrile infants. Pediatr Emerg Care 1987; 3:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/37\">",
"      Crain EF, Gershel JC. Urinary tract infections in febrile infants younger than 8 weeks of age. Pediatrics 1990; 86:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/38\">",
"      Lin DS, ",
"1ff8",
"Huang SH, Lin CC, et al. Urinary tract infection in febrile infants younger than eight weeks of Age. Pediatrics 2000; 105:E20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/39\">",
"      Stamm WE. Measurement of pyuria and its relation to bacteriuria. Am J Med 1983; 75:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/40\">",
"      Pappas PG. Laboratory in the diagnosis and management of urinary tract infections. Med Clin North Am 1991; 75:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/41\">",
"      Shaw KN, McGowan KL, Gorelick MH, Schwartz JS. Screening for urinary tract infection in infants in the emergency department: which test is best? Pediatrics 1998; 101:E1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/42\">",
"      Sharief N, Hameed M, Petts D. Use of rapid dipstick tests to exclude urinary tract infection in children. Br J Biomed Sci 1998; 55:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/43\">",
"      Tebruegge M, Pantazidou A, Clifford V, et al. The age-related risk of co-existing meningitis in children with urinary tract infection. PLoS One 2011; 6:e26576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/44\">",
"      Bachur R, Caputo GL. Bacteremia and meningitis among infants with urinary tract infections. Pediatr Emerg Care 1995; 11:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/45\">",
"      Huang YS, Wang SM, Liu CC, Yang YJ. Invasive Escherichia coli infection in infancy: clinical manifestation, outcome, and antimicrobial susceptibility. J Microbiol Immunol Infect 2002; 35:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/46\">",
"      Byington CL, Rittichier KK, Bassett KE, et al. Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens. Pediatrics 2003; 111:964.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Tables of antibacterial drug doses. In: Red Book: 20012 Report of the Committee on Infectious Diseases, 29th ed, Pickering LK (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2012. p.808.",
"    </li>",
"    <li>",
"     Young TE, Magnum B. NeoFax: A Manual of Drugs Used in Neonatal Care, 14th ed, Acorn Publishing, Raleigh 2001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/49\">",
"      Mentzel HJ, Vogt S, Patzer L, et al. Contrast-enhanced sonography of vesicoureterorenal reflux in children: preliminary results. AJR Am J Roentgenol 1999; 173:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/50\">",
"      Piepsz A, Blaufox MD, Gordon I, et al. Consensus on renal cortical scintigraphy in children with urinary tract infection. Scientific Committee of Radionuclides in Nephrourology. Semin Nucl Med 1999; 29:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/51\">",
"      Benador D, Benador N, Slosman D, et al. Are younger children at highest risk of renal sequelae after pyelonephritis? Lancet 1997; 349:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/52\">",
"      Benador D, Benador N, Slosman DO, et al. Cortical scintigraphy in the evaluation of renal parenchymal changes in children with pyelonephritis. J Pediatr 1994; 124:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/53\">",
"      Assael BM, Guez S, Marra G, et al. Congenital reflux nephropathy: a follow-up of 108 cases diagnosed perinatally. Br J Urol 1998; 82:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/54\">",
"      Stock JA, Wilson D, Hanna MK. Congenital reflux nephropathy and severe unilateral fetal reflux. J Urol 1998; 160:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14264/abstract/55\">",
"      Hellstr&ouml;m M, Jacobsson B, Jodal U, et al. Renal growth after neonatal urinary tract infection. Pediatr Nephrol 1987; 1:269.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4959 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-218.28.111.102-E73EFF4BA8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_59_14264=[""].join("\n");
var outline_f13_59_14264=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H776291741\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Virulence factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Hematogenous infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Urinary tract abnormalities",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Full-term infants",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Preterm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Uncircumcised males",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Term infants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Urine collection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Suprapubic aspiration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Bladder catheterization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Urinalysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Sepsis evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      RADIOGRAPHIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Renal ultrasound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Voiding cystourethrogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Other imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H776291741\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/1/27674?source=related_link\">",
"      Acute management, imaging, and prognosis of urinary tract infections in infants and children old",
"de3",
"er than one month",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/60/24519?source=related_link\">",
"      Approach to neonatal cholestasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/46/16102?source=related_link\">",
"      Bacterial adherence and other virulence factors for urinary tract infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/40/21129?source=related_link\">",
"      Clinical features and diagnosis of urinary tract infections in infants and children older than one month",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41705?source=related_link\">",
"      Neonatal circumcision: Risks and benefits",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/3/39992?source=related_link\">",
"      Pathogenesis and etiology of unconjugated hyperbilirubinemia in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/5/1107?source=related_link\">",
"      Patient information: Circumcision in baby boys (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/10/3242?source=related_link\">",
"      Presentation, diagnosis, and clinical course of vesicoureteral reflux",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_59_14265="Abdominal aortic aneurysm extending to the iliac bifurcation";
var content_f13_59_14265=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F87334&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F87334&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 618px\">",
"   <div class=\"ttl\">",
"    Abdominal aortic aneurysm extending to the iliac bifurcation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 598px; height: 400px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The&nbsp;axial contrast-enhanced CT shows that the abdominal aortic diameter&nbsp;is normal at the level of the renal arteries&nbsp;(A, arrow), and well below the renal arteries (B). A fusiform&nbsp;dilation (C) begins at the level or&nbsp;the third lumbar vertebra and&nbsp;extends to the iliac bifurcation (D) but does not extend into the common&nbsp;iliac arteries. The sagittal view (E)&nbsp;shows the distal fusiform aneurysm with luminal&nbsp;thrombus.",
"    <div class=\"footnotes\">",
"     CT: computed tomography.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_59_14265=[""].join("\n");
var outline_f13_59_14265=null;
var title_f13_59_14266="Clinical manifestations and diagnosis of Chagas heart disease";
var content_f13_59_14266=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of Chagas heart disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/59/14266/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/59/14266/contributors\">",
"     J Antonio Marin-Neto, MD, PhD, FACC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/59/14266/contributors\">",
"     Benedito C Maciel, MD, FACC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/59/14266/contributors\">",
"     Marcus V Sim&otilde;es, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/59/14266/contributors\">",
"     Andre Schmidt, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/59/14266/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/59/14266/contributors\">",
"     William J McKenna, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/59/14266/contributors\">",
"     Peter F Weller, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/59/14266/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/59/14266/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/59/14266/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/59/14266/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 13, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chagas disease (CD) is caused by Trypanosoma cruzi, a protozoan parasite that can cause acute myopericarditis as well as chronic fibrosing myocarditis. Chagas myocarditis is the most common cause of non-ischemic cardiomyopathy in Latin America [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The natural history of Chagas heart disease comprises an acute phase, an indeterminate form, and a cardiomyopathy form in the chronic phase. Most patients with acute disease have no or mild nonspecific symptoms and symptomatic myocarditis is rare. The indeterminate form is comprised of patients with evidence of T. cruzi infection without specific overt clinical evidence of cardiac or gastrointestinal disease. Approximately one-third to one-half of patients with indeterminate disease eventually develops chronic Chagas cardiomyopathy (CCC).",
"   </p>",
"   <p>",
"    Among 499 initially healthy blood donors in Brazil noted to have T. cruzi seropositivity on initial screening, 24 percent went on to develop Chagas cardiomyopathy during mean 10.5 years of follow-up; of these, 26 percent of patients presented with ejection fraction &lt;50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/2\">",
"     2",
"    </a>",
"    ]. Among 488 matched individuals with T. cruzi seronegativity, 5 percent developed cardiomyopathy during mean 11 years of follow-up. It is important to emphasize that the high annual incidence of Chagas cardiomyopathy noted in this study should not be extrapolated to the universe of individuals with the indeterminate form of Chagas disease, since it was a retrospective cohort study and no assessment of cardiac function by ECG or chest X-rays had been performed at the time of the initial seropositivity screening. This implies that at least some of the individuals could already be cardiomyopathy patients at the outset of the study despite presenting at the blood bank without symptoms.",
"   </p>",
"   <p>",
"    The clinical manifestations, diagnosis and evaluation of cardiac involvement in CD will be reviewed here. Other issues related to CD, including treatment of Chagas heart disease, prognosis of CCC and noncardiac manifestations are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/51/16184?source=see_link\">",
"     \"Treatment and prognosis of Chagas heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/34/551?source=see_link\">",
"     \"Chagas disease: Natural history and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/32/19975?source=see_link\">",
"     \"Pathology and pathogenesis of Chagas disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/22/16742?source=see_link\">",
"     \"Gastrointestinal Chagas disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/1/14356?source=see_link\">",
"     \"Antitrypanosomal drug therapy for Chagas disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/57/2969?source=see_link\">",
"     \"Chagas disease: Management of acute disease, early chronic disease, and disease in immunocompromised hosts\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ACUTE PHASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The acute phase of CD begins after an incubation period of one week to four months following exposure to T. Cruzi. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/34/551?source=see_link&amp;anchor=H541206326#H541206326\">",
"     \"Chagas disease: Natural history and diagnosis\", section on 'Acute phase'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16764324\">",
"    <span class=\"h2\">",
"     Symptoms and signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with acute CD are asymptomatic or have a relatively mild nonspecific febrile illness. The diagnosis is established during the acute phase in less than 10 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/34/551?source=see_link&amp;anchor=H541206326#H541206326\">",
"     \"Chagas disease: Natural history and diagnosis\", section on 'Acute phase'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most patients have generalized symptoms and signs such as fever and myalgia. A minority of patients have signs of heart failure, which is associated with significant risk of early mortality. The frequency and severity of clinical manifestations in the acute phase, including mortality due to myocarditis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    meningitis-encephalitis, are inversely proportional to age [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The symptoms and signs of cardiac involvement in acute Chagas [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/5,6\">",
"     5,6",
"    </a>",
"    ] are similar to those of myocarditis or myopericarditis due to other causes, and include dyspnea, fatigue (and other symptoms and signs of heart failure), chest pain, arrhythmias, and sudden cardiac arrest as discussed in detail separately (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/16/26889?source=see_link\">",
"     \"Clinical manifestations and diagnosis of myocarditis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/60/41927?source=see_link&amp;anchor=H4#H4\">",
"     \"Myopericarditis\", section on 'Clinical presentation'",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16764331\">",
"    <span class=\"h2\">",
"     Test results",
"    </span>",
"    &nbsp;&mdash;&nbsp;During the first weeks of infection, serologic tests for T. cruzi infection are usually negative and other test findings are nonspecific (including leukocytosis with an absolute increase in lymphocyte count). Since the level of parasitemia is high in the acute phase, the diagnosis is based upon detection of circulating parasites by a variety of methods. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/34/551?source=see_link&amp;anchor=H541206395#H541206395\">",
"     \"Chagas disease: Natural history and diagnosis\", section on 'Acute phase'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although symptoms and signs of cardiac disease are commonly lacking, myocardial involvement is likely present in most if not nearly all patients diagnosed with acute CD [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/7\">",
"     7",
"    </a>",
"    ]. Cardiac test findings are nonspecific but denote the presence of myocarditis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/3,5,6\">",
"     3,5,6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Electrocardiographic findings may include low voltage, bundle branch block, diffuse ST-T wave changes, or prolonged PR interval or more advanced AV block (",
"      <a class=\"graphic graphic_waveform graphicRef59915 \" href=\"UTD.htm?30/22/31075\">",
"       waveform 1",
"      </a>",
"      ). Sinus tachycardia is commonly present and the heart rate is often higher than attributable to fever alone. Arrhythmias such as atrial fibrillation, ventricular premature beats, and ventricular tachycardia are uncommon. During recovery, the electrocardiographic findings resolve in over 90 percent of patients within one year.",
"     </li>",
"     <li>",
"      The chest x-ray frequently demonstrates an enlarged cardiac silhouette (cardiac-to-thoracic width ratio above 50 percent) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef52718 \" href=\"UTD.htm?23/52/24387\">",
"       image 1",
"      </a>",
"      ), which is usually due to presence of a pericardial effusion as demonstrated by echocardiography.",
"     </li>",
"     <li>",
"      Echocardiography often demonstrates a pericardial effusion. Left ventricular dilation is less commonly present. Global left ventricular ejection fraction is often normal or near normal, even among patients with regional wall motion abnormalities (anterior",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      apical dyskinesis or septal dyskinesis) or left ventricular dilatation, although a minority have depressed global systolic function. Mitral regurgitation",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      tricuspid regurgitation are frequently present. Valvular regurgitation often resolves after etiologic treatment of CD.",
"     </li>",
"     <li>",
"      The frequency of myocardial involvement was demonstrated by a study of 58 patients with acute CD in which myocarditis was found in all 26 undergoing endomyocardial biopsy, including eight patients with no other evidence of heart disease [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/5\">",
"       5",
"      </a>",
"      ]. Typical findings are inflammatory changes with or without fibrosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3863000\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of acute CD is made by detection of circulating parasites by a variety of methods. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/34/551?source=see_link&amp;anchor=H541206395#H541206395\">",
"     \"Chagas disease: Natural history and diagnosis\", section on 'Acute phase'",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"    In patients with cardiac symptoms and signs, echocardiography is indicated to evaluate myocardial and pericardial disease and direct treatment.",
"   </p>",
"   <p>",
"    Endomyocardial biopsy is generally not required to establish the diagnosis, except in the context of patients following cardiac transplantation, when the distinction between Chagas myocarditis and implant rejection is crucial. Intracellular T. cruzi amastigote nests are occasionally identified.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3864581\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute Chagas heart disease has a similar presentation to other causes of myocarditis and myopericarditis; these include infectious agents, cardiotoxins, hypersensitivity reactions, systemic disorders, and radiation (",
"    <a class=\"graphic graphic_table graphicRef56995 \" href=\"UTD.htm?35/10/36014\">",
"     table 1",
"    </a>",
"    ). Acute CD should be considered in the differential diagnosis, particularly in those exposed to the appropriate endemic setting, and can be distinguished from other types of myocarditis and myopericarditis by detection of parasitemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/16/26889?source=see_link\">",
"     \"Clinical manifestations and diagnosis of myocarditis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/60/41927?source=see_link&amp;anchor=H4#H4\">",
"     \"Myopericarditis\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16764346\">",
"    <span class=\"h2\">",
"     Course",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute phase symptoms and signs typically resolve over a period of one to three months. Mortality among patients diagnosed during the acute phase is about 5 percent and occurs predominantly in the setting of refractory heart failure, with or without encephalitis. Sudden death occurs rarely and is associated with heart failure although it can occur without heart failure with a normal ejection in the presence of regional wall motion abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Management of acute disease is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/57/2969?source=see_link&amp;anchor=H107060876#H107060876\">",
"     \"Chagas disease: Management of acute disease, early chronic disease, and disease in immunocompromised hosts\", section on 'Acute Chagas disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/51/16184?source=see_link&amp;anchor=H372251516#H372251516\">",
"     \"Treatment and prognosis of Chagas heart disease\", section on 'Acute and indeterminate disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     INDETERMINATE FORM",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16764838\">",
"    <span class=\"h2\">",
"     Definition",
"    </span>",
"    &nbsp;&mdash;&nbsp;The indeterminate (or latent) form of CD is classically characterized by absence of symptoms, physical signs, 12-lead-electrocardiographic abnormalities, and any radiographic evidence (on chest x-ray,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    -contrast esophageal, or colon radiographs) of cardiac or gastrointestinal involvement in patients with serologic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    parasitologic evidence of chronic Trypanosoma cruzi infection [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. However, further cardiovascular testing may demonstrate significant abnormalities in these patients.",
"   </p>",
"   <p>",
"    The 2011 Latin American guidelines, in keeping with the classical concept of the indeterminate form, have adopted a definition that includes patients with clinically silent echocardiographic abnormalities who lack cardiomegaly on chest x-ray [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/10\">",
"     10",
"    </a>",
"    ]. This guideline decision is explained by limited observational data suggesting that the prognosis for patients with the classically defined indeterminate form including a normal electrocardiogram, is generally the same as control individuals without chagasic infection [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. The guideline committee generally felt that a policy of investigating all patients with the indeterminate form for the presence of left ventricular systolic dysfunction, would not be cost-effective, given the low expected prevalence of this derangement in such patients. (See",
"    <a class=\"local\" href=\"#H114864642\">",
"     'Electrocardiogram'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    However, the classic definition of the indeterminate form is subject to several limitations including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Additional testing with echocardiography, Holter monitoring, and exercise testing may demonstrate significant abnormalities in patients categorized as having the indeterminate form as discussed below [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/10,13,14\">",
"       10,13,14",
"      </a>",
"      ]. Echocardiography is now readily available in most clinical settings, and it is known that regional LV wall abnormalities (including the typical apical aneurysm) may precede detection of cardiomegaly on chest radiographs.",
"      <br/>",
"      <br/>",
"      Thus, an alternative definition of the indeterminate form has been proposed that includes demonstration of normal left ventricular global and regional systolic function by two-dimensional echocardiography [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Since asymptomatic patients are usually reluctant to undergo a",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      enema test, many studies purporting to focus on the indeterminate form have ignored this criterion. It seems reasonable not to require the performance of barium enema in patients without constipation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other tests that may reveal abnormalities in patients categorized as having the indeterminate form include radionuclide imaging, magnetic resonance imaging, autonomic evaluation, electrophysiologic testing, cardiac catheterization, and endomyocardial biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/10,16-18\">",
"     10,16-18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3863105\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with serologic evidence of chronic CD should be evaluated for cardiac involvement with a medical history, physical examination, and resting 12-lead electrocardiogram (ECG) preferably with a 30-second lead II rhythm strip [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/14\">",
"     14",
"    </a>",
"    ] and chest x-ray [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/10\">",
"     10",
"    </a>",
"    ], as well as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    esophageal and colon studies.",
"   </p>",
"   <p>",
"    The indeterminate form of CD is diagnosed in patients with serologic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    parasitologic evidence of Trypanosoma cruzi infection who lack symptoms, physical signs, electrocardiographic abnormalities and any radiographic evidence (on chest x-ray,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    -contrast esophageal, or colon radiographs) of cardiac or gastrointestinal involvement.",
"   </p>",
"   <p>",
"    Although not included in classical criteria for the indeterminate form, echocardiography is suggested as an additional test where resources allow. As noted above, an alternative definition of the indeterminate form includes demonstration of normal left ventricular global and regional systolic function by two-dimensional echocardiography [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3863119\">",
"    <span class=\"h2\">",
"     Monitoring guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no formal guidelines regarding the optimal approach to screening for development of left ventricular dysfunction for patients with the indeterminate form in the chronic phase of the disease. We suggest the following approach:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest repeating an ECG every one to two years and a chest x-ray every three to five years.",
"     </li>",
"     <li>",
"      We suggest echocardiographic assessment at infrequent but regular intervals (three to five years) for all patients with the indeterminate form of disease [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/18\">",
"       18",
"      </a>",
"      ], because we have found that the presence of even minor segmental LV systolic abnormalities predicts future global LV systolic dysfunction [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/19\">",
"       19",
"      </a>",
"      ]. In addition, overt chronic CD may first manifest as stroke or cardiac arrhythmias; many patients with these complications have regional LV systolic dysfunction [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/20,21\">",
"       20,21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Monitoring of brain natriuretic peptide (BNP) plasma levels may be a useful tool to identify patients who should undergo echocardiography. In a controlled study of 151 patients seropositive for CD (90 percent of whom had an LVEF &gt;40 percent), among those with an abnormal EKG or chest x-ray, plasma BNP &ge;60.7",
"    <span class=\"nowrap\">",
"     pmol/L",
"    </span>",
"    had good sensitivity and specificity for detection of LV dysfunction (80 and 97 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/22\">",
"     22",
"    </a>",
"    ]. Further studies are needed to determine the utility and cost-effectiveness of this approach prior to implementation in endemic areas.",
"   </p>",
"   <p>",
"    The presence of gastrointestinal tract symptoms (eg, dysphagia, constipation) should prompt evaluation with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    contrast studies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/22/16742?source=see_link\">",
"     \"Gastrointestinal Chagas disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16765712\">",
"    <span class=\"h2\">",
"     Course",
"    </span>",
"    &nbsp;&mdash;&nbsp;The indeterminate form may persist for decades. About one-third to one-half of patients with the indeterminate form develops cardiomyopathy after a latent period ranging from 5 to 30 years [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/10\">",
"     10",
"    </a>",
"    ]. Approximately 10 to 15 percent of chronically infected patients develop gastrointestinal disease, and a subset of patients develops cardiac and gastrointestinal (cardiodigestive) disease [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/34/551?source=see_link&amp;anchor=H541206350#H541206350\">",
"     \"Chagas disease: Natural history and diagnosis\", section on 'Chronic phase'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/22/16742?source=see_link\">",
"     \"Gastrointestinal Chagas disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CHRONIC CHAGAS CARDIOMYOPATHY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2158442\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with chronic Chagas cardiomyopathy (CCC) may be asymptomatic or present with symptoms such as dyspnea on exertion, fatigue, palpitations, dizziness, syncope, and edema. Symptoms arise from heart failure, cardiac arrhythmias, and thromboembolism caused by CCC. Chest pain is also common. Patients with chronic Chagas heart disease usually present with biventricular heart failure although occasionally the first clinical manifestation is cardiac arrhythmia or stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/10,18,20\">",
"     10,18,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cardiac examination typically demonstrates one or more of the following findings (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=see_link\">",
"     \"Auscultation of cardiac murmurs\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22410?source=see_link\">",
"     \"Auscultation of heart sounds\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Murmurs of mitral",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      tricuspid regurgitation",
"     </li>",
"     <li>",
"      Wide splitting of the second heart sound due to right bundle branch block",
"     </li>",
"     <li>",
"      A prominent diffuse apical thrust",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16765171\">",
"    <span class=\"h2\">",
"     Major clinical disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical manifestations of chronic Chagas heart disease (also known as chronic Chagas cardiomyopathy, CCC) arise from four major types of disorders: heart failure, cardiac arrhythmias, thromboembolism (systemic and pulmonary), and chest pain syndrome. These disorders frequently occur concurrently. Patients with chronic Chagas heart disease usually present with biventricular heart failure although occasionally the first clinical manifestation is cardiac arrhythmia or stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/10,18,20\">",
"     10,18,20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Heart failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heart failure in CCC usually presents with evidence of biventricular dysfunction including fatigue, chest pain, and fatigue. Manifestations of right-sided failure (increased jugular venous pressure, peripheral edema, ascites, and hepatomegaly) are frequently more pronounced than those of left-sided failure (dyspnea and pulmonary rales).",
"   </p>",
"   <p>",
"    Both systolic and diastolic dysfunction can occur. Diastolic dysfunction has been observed in the absence of regional or global left ventricular (LV) systolic dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19945?source=see_link\">",
"     \"Evaluation of the patient with suspected heart failure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/22/43368?source=see_link\">",
"     \"Clinical manifestations and diagnosis of diastolic heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Abnormalities in ventricular structure and function are discussed below. (See",
"    <a class=\"local\" href=\"#H114864649\">",
"     'Echocardiography'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Arrhythmias",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac arrhythmias are common in patients with CCC. Arrhythmias may be asymptomatic or cause palpitations, lightheadedness, dizziness, dyspnea, weakness, syncope, or sudden cardiac arrest. Complete heart block may cause dizziness or syncope. Autonomic dysfunction in the setting of CD results in marked abnormalities in the heart rate response to stimuli such as the Valsalva maneuver, exercise, and postural changes.",
"   </p>",
"   <p>",
"    Virtually all types of atrial and ventricular arrhythmias occur, including sinus node dysfunction, intermittent complete atrio-ventricular block, and complex ventricular arrhythmias. Electrocardiography often demonstrates frequent premature depolarizations, runs of ventricular tachycardia (VT), atrial fibrillation, or complete atrioventricular (AV) block. Ventricular arrhythmias and AV block frequently occur concurrently. (See",
"    <a class=\"local\" href=\"#H114864642\">",
"     'Electrocardiogram'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The severity of ventricular arrhythmias tends to correlate with the degree of LV dysfunction, although some patients with VT and complete AV block have preserved global ventricular function, usually with regional wall motion abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is evidence suggesting that the mechanism of severe ventricular arrhythmia is related to the regional fibrosis and macro-re-entrant circuits. In an electrophysiologic study of 56 patients with CD and VT, patients with spontaneous sustained VT had a higher prevalence of wall motion abnormalities in the inferior",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    posterolateral segments than those with no sustained VT. Scar in those regions was the main source of VT-related re-entrant circuits. A re-entrant substrate for the development of sustained VT existed in at least 50 percent of patients manifesting only nonsustained VT [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another relevant pathophysiologic mechanism of severe ventricular arrhythmia and sudden death in CCC may be related to the extensive myocardial sympathetic denervation found at the ventricular level. In a study involving 26 chagasic patients with mild left ventricular dysfunction, the detection of sustained ventricular tachycardia was associated with larger areas of viable but denervated myocardium identified by MIBG-I123 scintigraphy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sudden cardiac death accounts for approximately 55 to 65 percent of deaths in patients with chronic CD. The true frequency of this complication is probably underestimated, particularly in rural areas [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/20\">",
"     20",
"    </a>",
"    ]. Sudden death is often precipitated by exercise, and can be caused by VT or fibrillation, asystole, or complete AV block [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/27\">",
"     27",
"    </a>",
"    ]. Most patients with sudden cardiac arrest have severe underlying heart disease, although sudden death has been reported in previously asymptomatic patients [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10250731\">",
"    <span class=\"h3\">",
"     Pulmonary and systemic emboli",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thromboembolism is an important cause of stroke and other morbidity in patients with CD. It has been postulated that systemic emboli arise from mural thrombi, which form in dilated cardiac chambers, particularly in left ventricular aneurysms. Emboli may arise from the atria in those with atrial fibrillation. Pulmonary emboli arise from venous thrombi and possibly also from right heart thrombi.",
"   </p>",
"   <p>",
"    Scant data are available on overall rates of clinical thromboembolism but high rates of thromboembolic disease have been observed in autopsy series. In a review of 1345 autopsies with Chagas heart disease thromboemboli",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    intracardiac thrombi were observed in 44 percent of cases including 36 percent with pulmonary embolism [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/28\">",
"     28",
"    </a>",
"    ]. Thrombi were equally frequent in right and left cardiac chambers. Death was attributable to thromboemboli in 14 percent of patients with thromboembolic disease. Thromboembolic phenomena were more common in the systemic circulation but more deaths were caused by pulmonary embolism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11402164\">",
"    <span class=\"h4\">",
"     Stroke",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data on the risk of stroke in chronic CD are limited. Small series reported incidence rates of ischemic stroke in patients with Chagas cardiomyopathy of 1.2 and 2.7 percent per year [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prevalence of stroke in patients with Chagas cardiomyopathy may be greater than that in patients with cardiac dysfunction from other causes (eg, 15 versus 6 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Characteristics of CD patients with stroke were identified in a study of 94 CD patients presenting with acute ischemic stroke who were compared with a control group of 150 stroke patients without CD. Those with CD had significantly higher rates of cardioembolic stroke (56 versus 9 percent), left ventricular dilatation (23 versus 5 percent), mural thrombus (12 versus 2 percent), apical aneurysm (37 versus 1 percent), and atrial fibrillation (14 versus 5 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/21\">",
"     21",
"    </a>",
"    ]. In a series of 213 patients with Chagas cardiomyopathy, risk factors for stroke included reduced left ventricular ejection fraction and enlarged left atrial volume indexed for body surface area [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many or most strokes in CD are attributable to emboli from enlarged or aneurysmal cardiac chambers",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    atrial fibrillation, although atherothrombosis and small vessel disease related strokes also occur [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/32\">",
"     32",
"    </a>",
"    ]. Vascular disease in patients with CD is likely related to traditional atherosclerotic risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9208?source=see_link&amp;anchor=H4#H4\">",
"     \"Etiology and classification of stroke\", section on 'Thrombosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/61/30682?source=see_link\">",
"     \"Secondary prevention of stroke: Risk factor reduction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10250777\">",
"    <span class=\"h3\">",
"     Chest pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest pain is a common symptom in patients with CCC with and without heart failure. It usually atypical but occasionally may mimic angina. Proposed mechanisms for chest pain include myocardial microvascular abnormalities or anomalous regulation of coronary vasomotion [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/34\">",
"     34",
"    </a>",
"    ]. Also, some patients with CCC have concurrent coronary artery disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18526194\">",
"    <span class=\"h2\">",
"     Test results",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16765636\">",
"    <span class=\"h3\">",
"     Serology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic infection is diagnosed by serologic methods that detect IgG antibodies to T. cruzi as discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/34/551?source=see_link&amp;anchor=H541206420#H541206420\">",
"     \"Chagas disease: Natural history and diagnosis\", section on 'Chronic phase'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H114864635\">",
"    <span class=\"h3\">",
"     Chest x-ray",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiomegaly is the most common radiographic finding (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef52718 \" href=\"UTD.htm?23/52/24387\">",
"     image 1",
"    </a>",
"    ). Pulmonary congestion in many cases is absent or mild. The typical pattern of cardiomegaly with relatively clear lung fields in patients with chronic CD is usually due to right ventricular dysfunction with tricuspid regurgitation [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/35\">",
"     35",
"    </a>",
"    ]. Pericardial effusion (which contributes to the appearance of cardiomegaly)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pleural effusion may be present",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H114864642\">",
"    <span class=\"h3\">",
"     Electrocardiogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common electrocardiographic (ECG) abnormalities are right bundle branch block (RBBB) often associated with left anterior fascicular block (LAFB), and diffuse ST-T changes (",
"    <a class=\"graphic graphic_waveform graphicRef59915 \" href=\"UTD.htm?30/22/31075\">",
"     waveform 1",
"    </a>",
"    ). Ventricular premature beats and runs of non-sustained VT may also be seen. Other frequent findings are abnormal Q waves, various degrees of atrio-ventricular block, QT interval prolongation, and variation in the QT interval (QT dispersion). In advanced disease, atrial fibrillation and low QRS voltage may be observed. Virtually all types of atrial and ventricular arrhythmias occur, including sinus node dysfunction, intermittent complete atrio-ventricular block, and complex ventricular arrhythmias.",
"   </p>",
"   <p>",
"    The ECG QRS score correlates with New York Heart Association functional class (",
"    <a class=\"graphic graphic_table graphicRef52683 \" href=\"UTD.htm?3/2/3117\">",
"     table 2",
"    </a>",
"    ) and the extent of myocardial scar as detected by late gadolinium enhancement on cardiac magnetic resonance imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H114864684\">",
"     'Cardiovascular magnetic resonance'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Electrocardiographic findings may have prognostic significance as illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with CD who have a normal ECG have the same risk of cardiovascular death as patients without CD [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/37-41\">",
"       37-41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a series of 738 adults with chronic CD followed for five years, isolated LAFB, VPBs, pathologic Q waves, and QT dispersion (along with left ventricular systolic dimension) were risk factors for Chagas disease-related mortality [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Continuous ambulatory electrocardiographic (Holter) monitoring may identify associated atrial and ventricular arrhythmias. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Arrhythmias'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H114864649\">",
"    <span class=\"h3\">",
"     Echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Echocardiographic abnormalities of cardiac structure and function are observed in symptomatic and asymptomatic patients with chronic CD [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/42\">",
"     42",
"    </a>",
"    ]. Left and right ventricular systolic function ranges from normal to severely impaired.",
"   </p>",
"   <p>",
"    In early stages of cardiac involvement, echocardiography may demonstrate one or more areas of dyssynergy with preserved global systolic function. These mild segmental left ventricular wall motion abnormalities may be predictors of subsequent ventricular function deterioration [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/19\">",
"     19",
"    </a>",
"    ]. Left ventricular apical aneurysm is common in patients with moderate to severe cardiac impairment (47 to 64 percent) and occurs in up to 9 percent of asymptomatic patients (",
"    <a class=\"graphic graphic_waveform graphicRef80211 \" href=\"UTD.htm?28/0/28678\">",
"     waveform 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef71631 \" href=\"UTD.htm?13/39/13937\">",
"     image 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/42\">",
"     42",
"    </a>",
"    ]. Right ventricular aneurysms are much less frequent, and some patients have apical aneurysms affecting both ventricles. Regional wall motion abnormalities may also occur elsewhere, particularly in the inferolateral wall, which is the most predominant source for macro-reentrant VT.",
"   </p>",
"   <p>",
"    More advanced disease is characterized by global ventricular dilatation and diffuse hypokinesis, often associated with mitral and tricuspid regurgitation. Moderate or severe LV dysfunction and a left ventricular aneurysm predict worse outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Right ventricular systolic function may also be impaired [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/43\">",
"     43",
"    </a>",
"    ], but these alterations are frequently inadequately assessed or overlooked in echocardiographic assessments.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16765997\">",
"    <span class=\"h3\">",
"     Stress testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest pain is common and is usually atypical but occasionally may mimic angina. Stress testing is helpful in selected patients with chronic CD with suspected epicardial coronary artery disease (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/58/2986?source=see_link\">",
"     \"Stress testing to determine prognosis and management of patients with known or suspected coronary heart disease\"",
"    </a>",
"    ). However, electrocardiographic changes during exercise are frequently uninterpretable due to baseline electrocardiographic abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/44\">",
"     44",
"    </a>",
"    ]. The comparative efficacy and relative significance of arrhythmia detected during Holter monitoring versus exercise testing has not been systematically evaluated [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Stress imaging with radionuclide perfusion imaging or echocardiography may be helpful in patients with uninterpretable electrocardiographic changes. However, fixed and reversible perfusion and wall motion abnormalities have been observed in many patients with chronic CD without epicardial coronary artery disease as illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Blunted heart rate responses and abnormal contractile responses were observed in a",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      stress echocardiography study of 26 patients with and without underlying segmental wall motion abnormalities, even in those without baseline abnormalities [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/46\">",
"       46",
"      </a>",
"      ]. Ten patients underwent coronary arteriography and results were normal. Some patients had a biphasic response with improvement at low dose and deterioration at peak dose. These findings are similar to those observed in patients with coronary disease, suggesting that ischemia may contribute to the LV dysfunction in Chagas heart disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27466?source=see_link\">",
"       \"Stress echocardiography in the diagnosis and prognosis of coronary heart disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Reversible, paradoxical, and irreversible perfusion defects on radionuclide myocardial perfusion imaging have been observed in patients with or without atypical angina (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef71959 \" href=\"UTD.htm?24/10/24751\">",
"       image 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/34\">",
"       34",
"      </a>",
"      ]. Perfusion defects are typically located in the posterior-inferior and apical segments, where wall motion abnormalities also predominate and where sympathetic denervation has been identified by iodine-123 (I-123) meta-iodobenzylguanidine (MIBG) uptake [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/47\">",
"       47",
"      </a>",
"      ]. Fixed perfusion defects reflect regional myocardial fibrosis and correspond to regions with impaired wall motion. Reversible perfusion defects occur in the presence of normal epicardial coronary arteries and have been ascribed to coronary microvasculature abnormalities which may be due to underlying inflammatory changes or abnormal regulation of coronary vasomotion [",
"      <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The contribution of microvascular dysfunction to myocardial damage in CCC is illustrated by a study of CD patients who underwent serial perfusion scintigraphy over a period of several years [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/49\">",
"     49",
"    </a>",
"    ]. Temporal deterioration of left ventricular function was associated with the extent of microvascular ischemia with evolution to fixed (fibrotic) lesions over time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H114864677\">",
"    <span class=\"h3\">",
"     Cardiac catheterization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coronary artery disease may present similarly to CD and is also observed as a comorbid condition in some patients with CCC. Coronary angiography is useful to diagnose coronary artery disease in selected Chagas patients, including those with uncertain diagnosis as well as patients who have CD and suspected concomitant coronary disease with unstable ischemic symptoms or high risk features for coronary artery disease (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef79255 \" href=\"UTD.htm?11/11/11441\">",
"     image 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/1/29722?source=see_link\">",
"     \"Coronary arteriography and revascularization for unstable angina or non-ST elevation acute myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/3/24633?source=see_link\">",
"     \"Diagnosis and management of ischemic cardiomyopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/28/3529?source=see_link&amp;anchor=H94289721#H94289721\">",
"     \"Overview of the care of patients with stable ischemic heart disease\", section on 'Coronary angiography and revascularization'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Contrast left ventricular x-ray angiography may reveal characteristic aneurysms, occasionally at multiple sites (posterior-lateral, inferior basal, or apical) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef53675 \" href=\"UTD.htm?35/12/36046\">",
"     image 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/24\">",
"     24",
"    </a>",
"    ], but it is generally not required since wall motion abnormalities and ventricular aneurysms are generally diagnosed by echocardiography (or CMR or radionuclide ventriculography).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H114864684\">",
"    <span class=\"h3\">",
"     Cardiovascular magnetic resonance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiovascular magnetic resonance (CMR) imaging can be helpful for assessment of left ventricular size and function if echocardiography is suboptimal. In addition, the presence and extent of myocardial fibrosis detected by late gadolinium enhancement appears to correlate with disease severity (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77078 \" href=\"UTD.htm?7/26/7590\">",
"     image 6",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    As an example, in a series of 51 patients with CD, myocardial fibrosis was evident in 20 percent of patients without clinical cardiac involvement, 85 percent with known cardiac involvement, and 100 percent with VT [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/50\">",
"     50",
"    </a>",
"    ]. The extent of fibrosis increased across these three groups (percent of left ventricular mass of 0.9, 16, and 25 percent, respectively). Another study found good correlation between the ECG QRS score and the extent of the ventricular fibrosis by CMR, both parameters being inversely correlated to left ventricular ejection fraction [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/36\">",
"     36",
"    </a>",
"    ]. In an ongoing series of consecutive patients with CD who recovered from sudden cardiac death, we have found that all have a large scar on CMR [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since CMR is well suited for a direct and precise evaluation of dimensions, contractility, and tissue characterization, it may represent the best approach to detect early right ventricular dysfunction, a marker of bad prognosis that has been underused in clinical practice [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/52\">",
"     52",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/3/34874?source=see_link&amp;anchor=H36992798#H36992798\">",
"     \"Clinical utility of cardiovascular magnetic resonance imaging\", section on 'Late gadolinium enhancement'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/3/34874?source=see_link&amp;anchor=H30#H30\">",
"     \"Clinical utility of cardiovascular magnetic resonance imaging\", section on 'Chagas heart disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H114864691\">",
"    <span class=\"h3\">",
"     Electrophysiologic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;General indications for electrophysiologic testing apply to patients with chronic CD. Electrophysiologic testing is warranted for assessment of sinus node function and atrioventricular conduction when the origin of symptoms remains uncertain after noninvasive evaluation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/51/22328?source=see_link\">",
"     \"Invasive cardiac electrophysiology studies: Bradyarrhythmias\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Electrophysiologic testing does not have prognostic utility in most patients with preserved LV function who have nonsustained VT or no spontaneous arrhythmia. In one study, including 72 patients with CD and preserved LV function and 400 to 1200 ventricular extrasystoles per hour, programmed stimulation did not induce sustained VT in any of the patients; 35 percent had nonsustained VT on Holter monitoring [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/53\">",
"     53",
"    </a>",
"    ]. During an average follow-up of 36 months, only 1 of the 72 patients had spontaneous sustained VT.",
"   </p>",
"   <p>",
"    Some have proposed a potential role for electrophysiologic testing for evaluation of survivors of sudden cardiac arrest (SCA) and those with sustained VT to determine prognosis and to select an appropriate device and antiarrhythmic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/53-55\">",
"     53-55",
"    </a>",
"    ], but limited data are available on the efficacy of such an approach. An observational study included 115 patients with CCC presenting with symptomatic VT [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/55\">",
"     55",
"    </a>",
"    ]. Patients were divided into three groups based upon their responses to electrophysiology testing after loading with a Class III antiarrhythmic (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/13/21721?source=see_link\">",
"     sotalol",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    ). Patients in group one had no induced sustained VT, those in group two had inducible tolerated sustained VT, and those in group three had inducible hemodynamically unstable VT. After a mean follow-up of 52 months, the mortality rate was significantly higher in group three as compared to groups one and two (69 versus 26 and 22 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16766057\">",
"    <span class=\"h3\">",
"     RVG",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radionuclide ventriculography is not generally required but enables assessment of left and right ventricular size and global and regional function when echocardiographic imaging (or CMR) is technically suboptimal or not available. Regional left ventricular wall motion abnormalities",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    global right ventricular dysfunction may be detected in some patients in whom overall left ventricular performance is preserved (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef74274 \" href=\"UTD.htm?40/40/41615\">",
"     image 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4658317\">",
"    <span class=\"h3\">",
"     Other imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;A potential role for myocardial SPECT imaging with iodine-123 labeled metaiodobenzylguanidine (MIBG-I123) in patients with CCC has been suggested by studies at specialized centers. Using this technique, areas of myocardial sympathetic denervation were demonstrated in most patients with CCC (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef66157 \" href=\"UTD.htm?39/42/40608\">",
"     image 8",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/47\">",
"     47",
"    </a>",
"    ]. MIBG-I123 defects can be detected even in patients with normal cardiac function and normal ECG, and may precede the development of regional wall motion abnormalities. In one series, the extent of myocardial denervation correlated with the occurrence of severe sustained ventricular tachycardia [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/26\">",
"     26",
"    </a>",
"    ]. The findings suggest that derangement of the cardiac autonomic innervation is an early notable feature of CCC.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10251025\">",
"    <span class=\"h3\">",
"     Endomyocardial biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endomyocardial biopsy is not generally performed in patients with CCC. In uncertain cases it may be rarely performed to exclude other causes of cardiomyopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/26/7592?source=see_link&amp;anchor=H4#H4\">",
"     \"Endomyocardial biopsy\", section on 'Indications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with CCC who undergo heart transplantation, endomyocardial biopsy is performed to monitor for acute cellular rejection. Examination of histologic sections for parasite nests and immunohistologic evidence of T. cruzi antigen may help distinguish acute cellular rejection from reactivated chagasic myocarditis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16765461\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic Chagas cardiomyopathy (CCC) is diagnosed in patients with serologic evidence of IgG antibodies to T. cruzi and evidence of Chagas heart disease who may or may not have cardiac symptoms (such as dyspnea, edema, and chest pain). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/34/551?source=see_link&amp;anchor=H541206420#H541206420\">",
"     \"Chagas disease: Natural history and diagnosis\", section on 'Chronic phase'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As noted above, patients with serologic evidence of chronic CD should be evaluated for cardiac involvement with a medical history, physical examination, and resting 12-lead electrocardiogram (ECG) preferably with a 30-second lead II rhythm strip [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/14\">",
"     14",
"    </a>",
"    ] and chest x-ray [",
"    <a class=\"abstract\" href=\"UTD.htm?13/59/14266/abstract/10\">",
"     10",
"    </a>",
"    ]",
"    <strong>",
"     .",
"    </strong>",
"   </p>",
"   <p>",
"    While electrocardiographic or chest x-ray abnormalities may suggest cardiac disease, a normal electrocardiogram and chest x-ray does not exclude cardiomyopathy. If cardiac symptoms or signs are present or electrocardiographic or chest x-ray findings are suggestive of Chagas heart disease, we suggest echocardiography and 24-hour ambulatory (Holter) ECG monitoring.",
"   </p>",
"   <p>",
"    Left",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    right ventricular regional or global systolic dysfunction, ventricular aneurysm, and intracavity thrombus are most frequently diagnosed by echocardiography. Cardiovascular magnetic resonance or radionuclide ventriculography are other methods to assess ventricular function if echocardiographic images are non-diagnostic. (See",
"    <a class=\"local\" href=\"#H114864649\">",
"     'Echocardiography'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H114864684\">",
"     'Cardiovascular magnetic resonance'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H16766057\">",
"     'RVG'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H755502\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis for chronic Chagas cardiomyopathy (CCC) includes ischemic heart disease and other types of cardiomyopathy (",
"    <a class=\"graphic graphic_table graphicRef78298 \" href=\"UTD.htm?26/53/27486\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef52168 \" href=\"UTD.htm?21/4/21582\">",
"     table 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef64479 \" href=\"UTD.htm?17/63/18429\">",
"     table 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef74268 \" href=\"UTD.htm?8/42/8876\">",
"     table 6",
"    </a>",
"    ) (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/28/39369?source=see_link\">",
"     \"Evaluation of the patient with heart failure or cardiomyopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/0/19465?source=see_link\">",
"     \"Causes of dilated cardiomyopathy\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    As noted above, CCC may present similarly to ischemic heart disease. Some patients with CCC have chest pain, which may or may not be typical for angina. Apical aneurysms similar to those seen in CCC are seen in patients with coronary artery disease with apical infarction. Some (but not all) segmental ventricular abnormalities in CCC are not in typical coronary distributions (eg, posteroapical thinning). Stress testing may not adequately distinguish CCC from coronary disease since fixed and reversible perfusion and wall motion abnormalities have been observed in many patients with chronic CD without epicardial coronary artery disease. Also, some patients have both CCC and coronary artery disease. Coronary angiography is helpful in establishing the presence and extent of coronary artery disease when the diagnosis is uncertain or when unstable coronary disease is suspected. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/28/3529?source=see_link&amp;anchor=H94289721#H94289721\">",
"     \"Overview of the care of patients with stable ischemic heart disease\", section on 'Coronary angiography and revascularization'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The apical aneurysm seen in some patients with the apical variant of hypertrophic cardiomyopathy can generally be distinguished from CCC by concomitant apical hypertrophy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/4/25673?source=see_link\">",
"     \"Left ventricular aneurysm and pseudoaneurysm following acute myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/59/28600?source=see_link&amp;anchor=H5#H5\">",
"     \"Types and pathophysiology of obstructive hypertrophic cardiomyopathy\", section on 'Apical HCM'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Advanced CCC with left ventricular cavity dilation and global hypokinesis can be distinguished from other causes of dilated cardiomyopathy by serologic testing and exclusion of other potential concomitant causes (",
"    <a class=\"graphic graphic_table graphicRef60494 \" href=\"UTD.htm?4/53/4958\">",
"     table 7",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/0/19465?source=see_link\">",
"     \"Causes of dilated cardiomyopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/28/39369?source=see_link\">",
"     \"Evaluation of the patient with heart failure or cardiomyopathy\"",
"    </a>",
"    .).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3863814\">",
"    <span class=\"h2\">",
"     Course",
"    </span>",
"    &nbsp;&mdash;&nbsp;The course, prognosis, and management of chronic Chagas cardiomyopathy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/51/16184?source=see_link&amp;anchor=H372250898#H372250898\">",
"     \"Treatment and prognosis of Chagas heart disease\", section on 'Prognosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H121325494\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chronic Chagas cardiomyopathy, a sequela of parasitic infection caused by Trypanosoma cruzi, is the most common cause of cardiomyopathy in Latin America. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The natural history of Chagas heart disease comprises an acute phase, an indeterminate form, and a cardiomyopathy form in the chronic phase. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most patients with acute CD are asymptomatic or have a relatively mild nonspecific febrile illness. Subclinical cardiac involvement is present in most patients with acute CD but a minority of patients present with clinical manifestations of myopericarditis (including dyspnea and other evidence of heart failure, chest pain, arrhythmias), meningitis, and death. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Acute phase'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The indeterminate form of CD is classically characterized by absence of symptoms, physical signs, 12-lead-electrocardiographic abnormalities, and any radiographic evidence (on chest x-ray,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      -contrast esophageal or colon radiographs) of cardiac or gastrointestinal involvement in patients with serologic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      parasitologic evidence of chronic Trypanosoma cruzi infection. However, further cardiovascular testing may demonstrate significant abnormalities in these patients. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Indeterminate form'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with suspected CD based on serology should undergo a medical history, physical examination, and resting 12-lead electrocardiogram (ECG) preferably with a 30-second lead II rhythm strip. If findings are suggestive of Chagas heart disease, further cardiac evaluation is warranted, including echocardiography and 24-hour ambulatory ECG monitoring. (See",
"      <a class=\"local\" href=\"#H16765461\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The optimal approach to screening for development of left ventricular dysfunction among patients presenting with the indeterminate form of disease is uncertain; we suggest echocardiographic assessment at regular intervals. (See",
"      <a class=\"local\" href=\"#H3863119\">",
"       'Monitoring guidelines'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H114864649\">",
"       'Echocardiography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most patients come to clinical attention with symptomatic complaints in the setting of chronic disease. In general, presentation with chronic Chagas disease (CD) occurs as a result of four clinical disorders that frequently overlap in the same patient: heart failure, cardiac arrhythmia, thromboembolism, and chest pain. (See",
"      <a class=\"local\" href=\"#H16765171\">",
"       'Major clinical disorders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Heart failure in Chagas heart disease is usually biventricular; both systolic and diastolic dysfunction can occur. The manifestations of right-sided failure (increased jugular venous pressure, peripheral edema, ascites, and hepatomegaly) are frequently more pronounced than those of left-sided failure (dyspnea and pulmonary rales). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Heart failure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cardiac arrhythmias may cause palpitation, lightheadedness, dizziness, or syncope. Dizziness and syncope may also occur due to complete heart block or to ventricular tachycardia. Sudden cardiac death accounts for 55 to 65 percent of deaths in patients with chronic CD. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Arrhythmias'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pulmonary and systemic thromboembolism occur as a result of clot formation in the setting of stagnant venous thrombosis or mural thrombosis because of atrial fibrillation",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      apical aneurysm. (See",
"      <a class=\"local\" href=\"#H10250731\">",
"       'Pulmonary and systemic emboli'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/1\">",
"      Schofield CJ, Dias JC. A cost-benefit analysis of Chagas disease control. Mem Inst Oswaldo Cruz 1991; 86:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/2\">",
"      Sabino EC, Ribeiro AL, Salemi VM, et al. Ten-Year Incidence of Chagas Cardiomyopathy Among Asymptomatic Trypanosoma cruzi-Seropositive Former Blood Donors. Circulation 2013; 127:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/3\">",
"      Dias JC, Kloetzel K. The prognostic value of the electrocardiographic features of chronic Chagas' disease. Rev Inst Med Trop Sao Paulo 1968; 10:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/4\">",
"      Dias JCP. Acute Chagas Disease. Mem Inst Oswaldo Cruz 1984; 79:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/5\">",
"      Parada H, Carrasco HA, A&ntilde;ez N, et al. Cardiac involvement is a constant finding in acute Chagas' disease: a clinical, parasitological and histopathological study. Int J Cardiol 1997; 60:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/6\">",
"      Bastos CJ, Aras R, Mota G, et al. Clinical outcomes of thirteen patients with acute chagas disease acquired through oral transmission from two urban outbreaks in northeastern Brazil. PLoS Negl Trop Dis 2010; 4:e711.",
"     </a>",
"    </li>",
"    <li>",
"     Marin-Neto JA, Sim&otilde;es MV, Maciel BC. Specific diseases: cardiomyopathies and pericardial diseases. Other cardiomyopathies. In: Evidence-Based Cardiology, 2nd ed, Yusuf S, Cairns JA, Camm AJ, et al (Eds), BMJ Books, London 2003. p.718.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/8\">",
"      Primeira Reuni&atilde;o de Pesquisa Aplicada em Doen&ccedil;a de Chagas. Validade do conceito de forma indeterminada. Rev Soc Bras Med Trop 1985;18:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/9\">",
"      Ribeiro AL, Rocha MO. [Indeterminate form of Chagas disease: considerations about diagnosis and prognosis]. Rev Soc Bras Med Trop 1998; 31:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/10\">",
"      Andrade JP, Marin Neto JA, Paola AA, et al. I Latin American Guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary. Arq Bras Cardiol 2011; 96:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/11\">",
"      Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet 2010; 375:1388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/12\">",
"      Ianni BM, Arteaga E, Frimm CC, et al. Chagas' heart disease: evolutive evaluation of electrocardiographic and echocardiographic parameters in patients with the indeterminate form. Arq Bras Cardiol 2001; 77:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/13\">",
"      Barros MV, Rocha MO, Ribeiro AL, Machado FS. Doppler tissue imaging to evaluate early myocardium damage in patients with undetermined form of Chagas' disease and normal echocardiogram. Echocardiography 2001; 18:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/14\">",
"      Bern C, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA 2007; 298:2171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/15\">",
"      Pazin-Filho A, Romano MM, Gomes Furtado R, et al. Left ventricular global performance and diastolic function in indeterminate and cardiac forms of Chagas' disease. J Am Soc Echocardiogr 2007; 20:1338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/16\">",
"      Marin-Neto JA, Bromberg-Marin G, Pazin-Filho A, et al. Cardiac autonomic impairment and early myocardial damage involving the right ventricle are independent phenomena in Chagas' disease. Int J Cardiol 1998; 65:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/17\">",
"      Barretto AC, Ianni BM. The undetermined form of Chagas' heart disease: concept and forensic implications. Sao Paulo Med J 1995; 113:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/18\">",
"      Marin-Neto JA, Almeida Filho OC, Pazin-Filho A, Maciel BC. [Indeterminate form of Chagas' disease. Proposal of new diagnostic criteria and perspectives for early treatment of cardiomyopathy]. Arq Bras Cardiol 2002; 79:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/19\">",
"      Pazin-Filho A, Romano MM, Almeida-Filho OC, et al. Minor segmental wall motion abnormalities detected in patients with Chagas' disease have adverse prognostic implications. Braz J Med Biol Res 2006; 39:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/20\">",
"      Rassi A Jr, Rassi SG, Rassi A. Sudden death in Chagas' disease. Arq Bras Cardiol 2001; 76:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/21\">",
"      Carod-Artal FJ, Vargas AP, Horan TA, Nunes LG. Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease. Stroke 2005; 36:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/22\">",
"      Ribeiro AL, dos Reis AM, Barros MV, et al. Brain natriuretic peptide and left ventricular dysfunction in Chagas' disease. Lancet 2002; 360:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/23\">",
"      Sousa AC, Marin-Neto JA, Maciel BC, et al. [Systolic and diastolic dysfunction in the indeterminate, digestive and chronic cardiac forms of Chagas' disease]. Arq Bras Cardiol 1988; 50:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/24\">",
"      Rassi J&uacute;nior A, Gabriel Rassi A, Gabriel Rassi S, et al. [Ventricular arrhythmia in Chagas disease. Diagnostic, prognostic, and therapeutic features]. Arq Bras Cardiol 1995; 65:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/25\">",
"      Sarabanda AV, Sosa E, Sim&otilde;es MV, et al. Ventricular tachycardia in Chagas' disease: a comparison of clinical, angiographic, electrophysiologic and myocardial perfusion disturbances between patients presenting with either sustained or nonsustained forms. Int J Cardiol 2005; 102:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/26\">",
"      Miranda CH, Figueiredo AB, Maciel BC, et al. Sustained ventricular tachycardia is associated with regional myocardial sympathetic denervation assessed with 123I-metaiodobenzylguanidine in chronic Chagas cardiomyopathy. J Nucl Med 2011; 52:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/27\">",
"      Mendoza I, Camardo J, Moleiro F, et al. Sustained ventricular tachycardia in chronic chagasic myocarditis: electrophysiologic and pharmacologic characteristics. Am J Cardiol 1986; 57:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/28\">",
"      Samuel J, Oliveira M, Correa De Araujo RR, et al. Cardiac thrombosis and thromboembolism in chronic Chagas' heart disease. Am J Cardiol 1983; 52:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/29\">",
"      Bestetti R. Stroke in a hospital-derived cohort of patients with chronic Chagas' disease. Acta Cardiol 2000; 55:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/30\">",
"      Nunes MC, Barbosa MM, Ribeiro AL, et al. Ischemic cerebrovascular events in patients with Chagas cardiomyopathy: a prospective follow-up study. J Neurol Sci 2009; 278:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/31\">",
"      Oliveira-Filho J, Viana LC, Vieira-de-Melo RM, et al. Chagas disease is an independent risk factor for stroke: baseline characteristics of a Chagas Disease cohort. Stroke 2005; 36:2015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/32\">",
"      Carod-Artal FJ, Vargas AP, Falcao T. Stroke in asymptomatic Trypanosoma cruzi-infected patients. Cerebrovasc Dis 2011; 31:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/33\">",
"      Carod-Artal FJ, Gascon J. Chagas disease and stroke. Lancet Neurol 2010; 9:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/34\">",
"      Marin-Neto JA, Marzullo P, Marcassa C, et al. Myocardial perfusion abnormalities in chronic Chagas' disease as detected by thallium-201 scintigraphy. Am J Cardiol 1992; 69:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/35\">",
"      Marin-Neto JA, Andrade ZA. [Why is there predominance of right heart failure in Chagas' disease?]. Arq Bras Cardiol 1991; 57:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/36\">",
"      Strauss DG, Cardoso S, Lima JA, et al. ECG scar quantification correlates with cardiac magnetic resonance scar size and prognostic factors in Chagas' disease. Heart 2011; 97:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/37\">",
"      Espinosa R, Carrasco HA, Belandria F, et al. Life expectancy analysis in patients with Chagas' disease: prognosis after one decade (1973-1983). Int J Cardiol 1985; 8:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/38\">",
"      Salles G, Xavier S, Sousa A, et al. Prognostic value of QT interval parameters for mortality risk stratification in Chagas' disease: results of a long-term follow-up study. Circulation 2003; 108:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/39\">",
"      Mady C, Cardoso RH, Barretto AC, et al. Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy. Circulation 1994; 90:3098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/40\">",
"      Acquatella H, Catalioti F, Gomez-Mancebo JR, et al. Long-term control of Chagas disease in Venezuela: effects on serologic findings, electrocardiographic abnormalities, and clinical outcome. Circulation 1987; 76:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/41\">",
"      Maguire JH, Hoff R, Sherlock I, et al. Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community. Circulation 1987; 75:1140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/42\">",
"      Acquatella H. Echocardiography in Chagas heart disease. Circulation 2007; 115:1124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/43\">",
"      Nunes Mdo C, Barbosa Mde M, Brum VA, Rocha MO. Morphofunctional characteristics of the right ventricle in Chagas' dilated cardiomyopathy. Int J Cardiol 2004; 94:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/44\">",
"      Sim&otilde;es MV, Ayres EM, Santos JL, et al. [Detection of myocardial ischemia in chronic Chagas disease patients with atypic precordial pain by exercise and Holter tests]. Arq Bras Cardiol 1993; 60:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/45\">",
"      Sgammini HO, Kuschnir E, Evequoz MC, et al. Evaluation of severe ventricular arrhythmias in chronic Chagas' heart disease by effort test and Holter monitoring. Braz J Med Biol Res 1985; 18:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/46\">",
"      Acquatella H, P&eacute;rez JE, Condado JA, S&aacute;nchez I. Limited myocardial contractile reserve and chronotropic incompetence in patients with chronic Chagas' disease: assessment by dobutamine stress echocardiography. J Am Coll Cardiol 1999; 33:522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/47\">",
"      Sim&otilde;es MV, Pintya AO, Bromberg-Marin G, et al. Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas' cardiomyopathy. Am J Cardiol 2000; 86:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/48\">",
"      Torres FW, Acquatella H, Condado JA, et al. Coronary vascular reactivity is abnormal in patients with Chagas' heart disease. Am Heart J 1995; 129:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/49\">",
"      Hiss FC, Lascala TF, Maciel BC, et al. Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas' cardiomyopathy. JACC Cardiovasc Imaging 2009; 2:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/50\">",
"      Rochitte CE, Oliveira PF, Andrade JM, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. J Am Coll Cardiol 2005; 46:1553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/51\">",
"      Volpe GJ, Trad HS, Koenigkam-Santos M, et al.. Evaluation of Chagas heart disease by cardiac magnetic resonance after an aborted sudden cardiac death event. J Cardiovasc Magn Reson 2012; 14:P176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/52\">",
"      Schmidt A, Maciel BC, Marin-Neto JA. Time is resonant for right ventricular evaluation. Curr Cardiovasc Imaging Rep 2011; 4:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/53\">",
"      Scanavacca M, Sosa E. Electrophysiologic study in chronic Chagas' heart disease. Sao Paulo Med J 1995; 113:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/54\">",
"      de Paola AA, Horowitz LN, Miyamoto MH, et al. Angiographic and electrophysiologic substrates of ventricular tachycardia in chronic Chagasic myocarditis. Am J Cardiol 1990; 65:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/55\">",
"      Leite LR, Fenelon G, Simoes A Jr, et al. Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol. J Cardiovasc Electrophysiol 2003; 14:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/59/14266/abstract/56\">",
"      Marin-Neto JA, Marzullo P, Sousa AC, et al. Radionuclide angiographic evidence for early predominant right ventricular involvement in patients with Chagas' disease. Can J Cardiol 1988; 4:231.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4955 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-5115C1355F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_59_14266=[""].join("\n");
var outline_f13_59_14266=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H121325494\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ACUTE PHASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16764324\">",
"      Symptoms and signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16764331\">",
"      Test results",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3863000\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3864581\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16764346\">",
"      Course",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      INDETERMINATE FORM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16764838\">",
"      Definition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3863105\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3863119\">",
"      Monitoring guidelines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16765712\">",
"      Course",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CHRONIC CHAGAS CARDIOMYOPATHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2158442\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16765171\">",
"      Major clinical disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Heart failure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10250731\">",
"      - Pulmonary and systemic emboli",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H11402164\">",
"      Stroke",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10250777\">",
"      - Chest pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18526194\">",
"      Test results",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16765636\">",
"      - Serology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H114864635\">",
"      - Chest x-ray",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H114864642\">",
"      - Electrocardiogram",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H114864649\">",
"      - Echocardiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16765997\">",
"      - Stress testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H114864677\">",
"      - Cardiac catheterization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H114864684\">",
"      - Cardiovascular magnetic resonance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H114864691\">",
"      - Electrophysiologic testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16766057\">",
"      - RVG",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4658317\">",
"      - Other imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10251025\">",
"      - Endomyocardial biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16765461\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H755502\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3863814\">",
"      Course",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H121325494\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/4955\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/4955|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/52/24387\" title=\"diagnostic image 1\">",
"      Chagas heart disease PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?13/39/13937\" title=\"diagnostic image 2\">",
"      Chagas heart disease Echo",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?24/10/24751\" title=\"diagnostic image 3\">",
"      Myocardial perfusion Chagas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?11/11/11441\" title=\"diagnostic image 4\">",
"      Chagas heart disease Angio",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?35/12/36046\" title=\"diagnostic image 5\">",
"      Left ventriculogram Chagas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?7/26/7590\" title=\"diagnostic image 6\">",
"      Chagas cardiomyopathy with late gadolinium enhancement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?40/40/41615\" title=\"diagnostic image 7\">",
"      Chagas heart radionuclide angio",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/42/40608\" title=\"diagnostic image 8\">",
"      Radionuclide imaging of Chagas cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/4955|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/10/36014\" title=\"table 1\">",
"      Causes of myocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/2/3117\" title=\"table 2\">",
"      Methods to assess cardiovascular disability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/53/27486\" title=\"table 3\">",
"      Causes of cardiomyopathy I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/4/21582\" title=\"table 4\">",
"      Causes of cardiomyopathy II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/63/18429\" title=\"table 5\">",
"      ESC 2008 CM familial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/42/8876\" title=\"table 6\">",
"      ESC 2008 CM nonfamilial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/53/4958\" title=\"table 7\">",
"      Causes dilated cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/4955|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?30/22/31075\" title=\"waveform 1\">",
"      Chagas heart disease ECG",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?28/0/28678\" title=\"waveform 2\">",
"      M mode Chagasic cardiomyopathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/1/14356?source=related_link\">",
"      Antitrypanosomal drug therapy for Chagas disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=related_link\">",
"      Auscultation of cardiac murmurs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22410?source=related_link\">",
"      Auscultation of heart sounds",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/0/19465?source=related_link\">",
"      Causes of dilated cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/57/2969?source=related_link\">",
"      Chagas disease: Management of acute disease, early chronic disease, and disease in immunocompromised hosts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/34/551?source=related_link\">",
"      Chagas disease: Natural history and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/22/43368?source=related_link\">",
"      Clinical manifestations and diagnosis of diastolic heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/16/26889?source=related_link\">",
"      Clinical manifestations and diagnosis of myocarditis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/3/34874?source=related_link\">",
"      Clinical utility of cardiovascular magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/1/29722?source=related_link\">",
"      Coronary arteriography and revascularization for unstable angina or non-ST elevation acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/3/24633?source=related_link\">",
"      Diagnosis and management of ischemic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/26/7592?source=related_link\">",
"      Endomyocardial biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9208?source=related_link\">",
"      Etiology and classification of stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/28/39369?source=related_link\">",
"      Evaluation of the patient with heart failure or cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19945?source=related_link\">",
"      Evaluation of the patient with suspected heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/22/16742?source=related_link\">",
"      Gastrointestinal Chagas disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/51/22328?source=related_link\">",
"      Invasive cardiac electrophysiology studies: Bradyarrhythmias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/4/25673?source=related_link\">",
"      Left ventricular aneurysm and pseudoaneurysm following acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/60/41927?source=related_link\">",
"      Myopericarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/28/3529?source=related_link\">",
"      Overview of the care of patients with stable ischemic heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/32/19975?source=related_link\">",
"      Pathology and pathogenesis of Chagas disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/61/30682?source=related_link\">",
"      Secondary prevention of stroke: Risk factor reduction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27466?source=related_link\">",
"      Stress echocardiography in the diagnosis and prognosis of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/58/2986?source=related_link\">",
"      Stress testing to determine prognosis and management of patients with known or suspected coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/51/16184?source=related_link\">",
"      Treatment and prognosis of Chagas heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/59/28600?source=related_link\">",
"      Types and pathophysiology of obstructive hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_59_14267="Contact lens care tips";
var content_f13_59_14267=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F50775&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F50775&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Contact lens care tips",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        &bull; Follow recommended wearing schedule.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Do",
"        <strong>",
"         not",
"        </strong>",
"        substitute sterile saline solutions for multi-purpose solutions.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Rub and rinse your contact lenses as directed by your eye care professional.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Do not \"top-off\" the solutions in your case. Always discard all of the leftover contact lens solution after each use. Never reuse any lens solution.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Clean, rinse and air-dry your lens case each time lenses are removed.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Do not expose your contact lenses to any water: tap, bottled, distilled, lake or ocean water.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Contact your eye care professional if you experience any symptoms of eye irritation or infection.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: US Food and Drug Administration, Medical Devices, Contact Lenses. Available at: www.fda.gov/cdrh/contactlenses/lenslist.html (Accessed on August 20th, 2009).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_59_14267=[""].join("\n");
var outline_f13_59_14267=null;
var title_f13_59_14268="Treatment of VWD";
var content_f13_59_14268=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F75956&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F75956&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Treatment of von Willebrand disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Medication",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Desmopressin (dDAVP)",
"       </td>",
"       <td>",
"        <p>",
"         IV: 0.3 &micro;g/kg in 50 mL saline over 20 min.",
"        </p>",
"        <p>",
"         Nasal spray: weight &gt;50 kg: 300 &micro;g (1 spray in each nostril); &lt;50 kg: 150 &micro;g (1 spray in one nostril)",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Useful in most patients with type 1; variable in type 2;* Not useful in type 3.",
"        </p>",
"        <p>",
"         Patient should have therapeutic trial to measure response before use.",
"        </p>",
"        <p>",
"         May repeat dose after 12 hr and 24 hr. Tachyphylaxis and hyponatremia may occur; need to monitor patient.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        VWF concentrates containing all VWF multimers",
"       </td>",
"       <td>",
"        <strong>",
"         Major bleeding or surgery:",
"        </strong>",
"        Initial dose 40-60 ristocetin cofactor units per kg followed by 20-40 ristocetin cofactor units per kg q 12-24 hr to keep VWF level 50-100 IU/dL for 7-14 days.",
"        <br/>",
"        <strong>",
"         Minor bleeding or surgery:",
"        </strong>",
"        Initial dose 30-60 ristocetin cofactor units per kg followed by 20-40 ristocetin cofactor units per kg q 12-48 hr to keep VWF level &gt;30 IU/dL for 3-5 days.",
"       </td>",
"       <td>",
"        Dose and duration based on clinical experience.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"3\">",
"        Antifibrinolytic agents:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Aminocaproic acid",
"       </td>",
"       <td class=\"sublist_other\">",
"        25-50 mg/kg (maximum 5 g dose) 4 x daily by mouth",
"       </td>",
"       <td class=\"sublist_other\" rowspan=\"2\">",
"        Use alone or in conjunction with other therapy. Especially useful for mucosal bleeding (often for dental procedures).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Tranexamic acid",
"       </td>",
"       <td class=\"sublist_other\">",
"        10 mg/kg 3 x daily IV",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IVIG (immune acquired inhibitors of VWF)",
"       </td>",
"       <td>",
"        1 g/kg daily for 2 days - infusion over 8-12 hr",
"       </td>",
"       <td>",
"        Use after trial of DDAVP or other measures in patients with acquired VWD, particularly when associated with autoimmune diseases.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Thrombocytopenia may worsen in some type 2B patients.",
"     <br>",
"      &bull; Oral preparation not available in the United States.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Rick, ME, Med Clin North Am 1994; 78:609. Copyright 1994 WB Saunders.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_59_14268=[""].join("\n");
var outline_f13_59_14268=null;
var title_f13_59_14269="DDx Foot ankle pain athlete C";
var content_f13_59_14269=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F58865&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F58865&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of foot and ankle pain in the young athlete (continued)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Condition",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mechanism",
"       </td>",
"       <td class=\"subtitle1\">",
"        Location of pain",
"       </td>",
"       <td class=\"subtitle1\">",
"        Radiograph",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Anterior ankle pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"4\">",
"        Anterior tibialis injuries",
"       </td>",
"       <td>",
"        Direct pressure",
"       </td>",
"       <td rowspan=\"4\">",
"        Anterior tibialis tendon (anteromedial ankle)",
"       </td>",
"       <td rowspan=\"4\">",
"        Not necessary for diagnosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Running on hard surface",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Overstriding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Excessive pronation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        High ankle sprain",
"       </td>",
"       <td>",
"        Hyperplantar flexion",
"       </td>",
"       <td rowspan=\"2\">",
"        Distally between the tibia and fibula",
"       </td>",
"       <td rowspan=\"2\">",
"        Plain radiographs of the ankle",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Forced external rotation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Posterior ankle pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"3\">",
"        Achilles tendinitis",
"       </td>",
"       <td>",
"        Repetitive microtrauma",
"       </td>",
"       <td rowspan=\"3\">",
"        Achilles tendon",
"       </td>",
"       <td rowspan=\"3\">",
"        Lateral weight bearing heel (to exclude bony abnormalities) MRI; ultrasonography",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Improper footwear",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Errors in training technique",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Achilles tendon rupture",
"       </td>",
"       <td>",
"        Sports activity",
"       </td>",
"       <td rowspan=\"2\">",
"        Calf",
"       </td>",
"       <td rowspan=\"2\">",
"        Ultrasonography in dorsiflexion and plantarflexion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trauma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Os trigonum",
"       </td>",
"       <td>",
"        Hyperplantarflexion",
"       </td>",
"       <td>",
"        Posterolateral talus",
"       </td>",
"       <td>",
"        Lateral ankle; lateral ankle in plantar flexion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Heel pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"2\">",
"        Calcaneal apophysitis (Sever disease)",
"       </td>",
"       <td>",
"        Footwear",
"       </td>",
"       <td rowspan=\"2\">",
"        Calcaneal apophysis (posterior heel)",
"       </td>",
"       <td rowspan=\"2\">",
"        Not necessary for diagnosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Overuse",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"4\">",
"        Plantar fasciitis",
"       </td>",
"       <td>",
"        Footwear",
"       </td>",
"       <td rowspan=\"4\">",
"        Medial calcaneal tubercle; arch",
"       </td>",
"       <td rowspan=\"4\">",
"        Not necessary for diagnosis; may be indicated to exclude other problems (lateral and axial views)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pes planus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pes cavus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Overuse",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Foot pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Rigid flat foot",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Consider CT scan to look for tarsal coalition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Flexible flat foot",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Obtain radiographs if the feet are painful, have restricted motion, or surgery is being considered",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tibialis posterior tendon dysfunction",
"       </td>",
"       <td>",
"        Increased stress along TPT (eg, dancers, skaters, running sports)",
"       </td>",
"       <td>",
"        Along TPT, usually distal to the medial malleolus",
"       </td>",
"       <td>",
"        AP, lateral foot; MRI depending upon stage of disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        High arched foot",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Weight-bearing radiographs of the foot and ankle; consider radiographs or MRI of the spine",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     MRI: magnetic resonance imaging; CT: computed tomography; TPT: tibialis posterior tendon; AP: anteroposterior.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_59_14269=[""].join("\n");
var outline_f13_59_14269=null;
var title_f13_59_14270="Blood culture followup in children 3 to 36 months of age";
var content_f13_59_14270=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F81743&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F81743&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Blood culture follow-up in children 3 to 36 months of age",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 348px; height: 381px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     BC: blood culture; LP: lumbar puncture; IV: intravenous.",
"     <br>",
"      * Well patients with blood culture positive for E. coli or S. aureus do not need a lumbar puncture; for other pathogens, which are encountered rarely, the decision should be individualized.",
"      <br>",
"       &bull; Outpatient care is only appropriate in patients without evidence of meningitis on CSF examination.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_59_14270=[""].join("\n");
var outline_f13_59_14270=null;
var title_f13_59_14271="12-lead ECG left posteroseptal WPW";
var content_f13_59_14271=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F71868&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F71868&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 518px\">",
"   <div class=\"ttl\">",
"    12-lead electrocardiogram (ECG) of a left posteroseptal accessory AV pathway",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 498px; height: 295px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electrocardiogram during right atrial pacing in a patient with Wolff-Parkinson-White syndrome shows a long stimulus to the P wave with a short PR interval, the appearance of both right and left bundle branch block morphologies, and a negative QRS morphology and delta wave in the inferior leads. This localizes the pathway to the posteroseptal area. The presence of a positive delta wave in lead I, RS ratio in lead V1 of approximately 1, and a negative delta wave in lead II places the pathway on the left side, inside the coronary sinus os or allong the middle cardiac vein. This type of accessory pathway may be related to cardiac venous anomalies and aneurysms.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_59_14271=[""].join("\n");
var outline_f13_59_14271=null;
